Page last updated: 2024-08-22

angiotensin ii and Chronic Disease

angiotensin ii has been researched along with Chronic Disease in 323 studies

Research

Studies (323)

Timeframe	Studies, this research(%)	All Research%
pre-1990	118 (36.53)	18.7374
1990's	46 (14.24)	18.2507
2000's	96 (29.72)	29.6817
2010's	57 (17.65)	24.3611
2020's	6 (1.86)	2.80

Authors

Authors	Studies
Fujioka, K; Hattori, T; Hirayama, M; Kagami, S; Kondo, S; Nagai, T; Urushihara, M	1
Aragno, M; Sansoè, G; Wong, F	1
Bishop, NM; Cipolla, MJ; Li, Z; Lindner, DP	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Cunningham, JT; Farmer, GE; Marciante, AB; Shell, B	1
Chan, YH; Chen, SW; Chou, AH; Chou, SH; Chu, PH; Ho, CT; Hsiao, FC; Hsu, ME; Kao, WWY; Lin, PJ; Tung, YC; Wu, VC	1
Kinugawa, S	1
Baiardi, G; Basmadjian, OM; Bregonzio, C; Marchese, NA; Occhieppo, VB	1
Abu-Izneid, T; Khan, H; Patel, S; Rauf, A	1
Collawn, JF; Dell'Italia, LJ; Ferrario, CM	1
Du, W; Li, X; Xiao, X; Zhang, F; Zhang, S; Zhang, Y; Zhu, M	1
Chen, X; Lin, Y; Luo, W; Shi, Y; Song, A; Wang, W; Zeng, Y; Zhang, Y	1
Cornelissen, G; El-Kilany, G; Fedacko, J; Hristova, K; Singh, RB	1
Blackburn, MR; Colgan, SP; Dai, Y; Eltzschig, HK; Glover, L; Grenz, A; Kellems, RE; Luo, R; Ning, C; Sun, H; Sun, K; Tao, L; Wang, W; Xia, Y; Zhang, W; Zhang, Y	1
Azuma, J; Ito, T; Schaffer, S	1
Llewellyn, TL; Patel, KP; Sharma, NM; Zheng, H	1
Caliari, MV; Campagnole-Santos, MJ; Cara, DC; Cardoso, JA; Kangussu, LM; Lautner, RQ; Magalhães, GS; Marques, FD; Murari, A; Noviello, ML; Oliveira, ML; Pereira, JM; Rodrigues-Machado, MG; Santos, RA	1
Ardell, JL; Beaumont, E; Hardwick, JC; Ryan, SE; Southerland, EM	1
Bhat, G; Sayer, G	1
Hart, A; Ibrahim, HN; Jackson, S; Kasiske, BL; Matas, AJ; Mauer, MS; Najafian, B; Spong, R	1
Burger, D; Chibale, K; Mahajan, A; Reudelhuber, TL; Sturrock, ED; Touyz, RM	1
Chen, D; Chen, LY; Gan, XB; Sun, HJ; Zhang, LL; Zhou, H; Zhou, YB	1
Carver, KA; Gallagher, PE; Smith, TL; Tallant, EA	1
Arutiunov, GP; Dragunov, DO; Sokolova, AV	1
Haack, KK; Zucker, IH	1
Cao, FF; Jiang, ZL; Li, YF; Liu, F	1
Li, YL; Liu, J; Muelleman, RL; Tu, H; Zhang, D; Zheng, H	1
Brands, MW; El-Shewy, HM; Fitzgibbon, WR; Garrett, SM; Jaffa, AA; Luttrell, LM; Wilson, PC	1
Delafontaine, P; Yoshida, T	2
Guo, WX; Li, H; Li, YR; Lin, JM; Liu, Y; Wang, Y; Zhou, J	1
Dong, Z; Huang, Q; Hultström, M; Lai, EY; Li, H; Qi, Y; Wang, H; Wang, R; Wei, X; Wilcox, CS; Wu, H; Zhou, R; Zhou, X	1
Bang, JH; Han, JS; Jeon, WK; Kang, HW; Kim, MS; Lee, J	1
Cornish, KG; Gao, L; Liu, D; Roy, SK; Zucker, IH	1
Felder, RB; Wei, SG; Weiss, RM; Yu, Y; Zhang, ZH	1
Agnew, C; Ding, Y; Li, YL; Schultz, HD	1
Miller, JD; Stickland, MK	1
Denton, KM; Flower, RL; Jones, ES; Moritz, KM; Sampson, AK; Widdop, RE	1
Collister, JP; Ployngam, T	1
Rockey, DC	1
Chen, YX; Nie, RQ; Wang, JF; Yao, YJ; Zhou, SX	1
Ma, Q; Ning, Y; Sun, M; Wu, S; Yang, L; Yang, T	1
Anegawa, T; Hirooka, Y; Ikeda, A; Imaizumi, T; Kai, H; Kajimoto, H; Kato, S; Koga, M; Kudo, H; Mifune, H; Mori, T; Takayama, N; Yasuoka, S	1
Gao, L; Patel, KP; Schultz, HD; Wang, W; Zucker, IH	1
Chu, Y; Heistad, DD; Miller, JD; Rosenberg, GA; Wakisaka, Y	1
Akie, Y; Aritomi, S; Nakamura, Y; Nakayama, A; Satoh, Y; Sugiyama, A; Takahara, A; Wagatsuma, H	1
Fogo, AB; Han, JY; Kon, V; Ma, LJ; Naito, T; Tang, Y; Yang, H; Zuo, Y	1
Finch, M; Gao, L; Li, Y; Schultz, HD; Smith, LM; Wang, W; Wang, WZ; Zucker, IH	1
Fink, GD; King, A; Miki, K; Osborn, JW; Yoshimoto, M	1
Burns, KD; Dilauro, M; Genest, D; Robertson, SJ; Zimpelmann, J	1
Collister, JP; Nahey, DB	1
Loriga, G	1
Baron-Menguy, C; Cousin, M; Custaud, MA; Dumont, O; Guihot, AL; Henrion, D; Loufrani, L; Subra, JF; Toutain, B; Vessières, E	1
Agrawal, AN; Axtell, R; Ding, Z; Ho, PP; Lanz, TV; Luo, J; Platten, M; Srinagesh, H; Steinman, L; Wyss-Coray, T; Zhang, H	1
Chen, R; Eisner, C; Hu, X; Huang, Y; Kopp, JB; Leelahavanichkul, A; Mizel, D; Schnermann, J; Star, RA; Wright, EC; Yan, Q; Yuen, PS; Zhou, H	1
Ghee, JY; Han, DH; Kim, S; Kobori, H; Kuro-o, M; Ohashi, N; Piao, S; Song, JH; Yang, CW; Yoon, HE	1
Ashraf, M; Bernard, LS; Davis, LE; Deng, YB; Hashima, JN; Hohimer, AR; Rasanen, J; Sahn, DJ; Shentu, W; Xiong, L; Zhou, Z	1
Kobori, H; Navar, LG; Prieto, MC; Satou, R	1
Machado, BH; Zoccal, DB	1
Dai, Y; Kellems, RE; Wen, J; Xia, Y; Zhang, W; Zhang, Y	1
Fanelli, C; Fernandes, BH; Fujihara, CK; Machado, FG; Malheiros, DM; Okabe, C; Zatz, R	1
Li, YF; Mehta, PP; Patel, KP; Sharma, NM; Zheng, H	1
Belatti, DA; Curry, PL; Gao, L; Kar, S; Zucker, IH	1
Bachmann, MF; Jennings, GT	1
Abbate, A; Dhaduk, R; Li, N; Li, PL; Van Tassell, BW; Wang, Z; Xia, M; Zhu, Q	1
Cui, BP; Duan, YC; Gan, XB; Gao, XY; Li, P; Xiong, XQ; Zhu, GQ	1
Sata, M	1
Bech, JN; Graffe, CC; Lauridsen, TG; Pedersen, EB	1
Barrett, CJ; Guild, SJ; Malpas, SC; McBryde, FD	1
Fletcher, JA; Matthew Morris, E; Rector, RS; Thyfault, JP	1
Engler, CW; Haack, KK; Papoutsi, E; Patel, KP; Pipinos, II; Zucker, IH	1
Feng, S; Lu, C; Lu, Y; Pan, Z; Ren, J; Shan, H; Sun, X; Wang, J; Wang, N; Wang, Y; Xie, L; Yang, B; Yuan, Y; Zhang, Y	1
Ardell, JL; Girasole, AE; Hardwick, JC; Negrotto, S; Ryan, SE; Southerland, EM	1
Cao, X; Davisson, RL; Guruju, MR; Iadecola, C; Mark, AL; Morgan, DA; Pierce, JP; Wang, G; Young, CN	1
Golledge, J; Seto, SW; Wang, Y	1
Clagett, GP; Levi, M; Modrall, JG; Moe, O; Puttaparthi, K; Rogers, TE; Sadjadi, J; Turnage, RH; Welborn, MB	1
Aros, C; Remuzzi, G	1
Colombo, PC; Jorde, UP; Katz, SD; Latif, F; Le Jemtel, TH; Vittorio, T	1
Bauer, F; Cardon, LA; Jones, M; Kim, YJ; Kwan, J; Qin, JX; Shiota, T; Sitges, M; Thomas, JD; Tsujino, H; Zetts, AD	1
Jorde, UP; Katz, SD; Lang, CC; Mancini, DM; Packer, M; Vittorio, TJ	1
Ahn, HJ; Bang, BK; Cha, JH; Jung, JY; Kim, J; Kim, WY; Kim, YS; Li, C; Yang, CW; Yoon, SA	1
Baartscheer, A; Balt, JC; Belterman, CN; Mathy, MJ; Nap, A; Pfaffendorf, M; Van Zwieten, PA	1
Bech, JN; Bentzen, H; Nyvad, O; Pedersen, EB; Pedersen, RS	1
Albåge, A; Berglund, H; Kennebäck, G; van der Linden, J	1
Buikema, H; de Zeeuw, D; Gschwend, S; Henning, RH; Pinto, YM; van Gilst, WH	1
Collister, JP; Hendel, MD	1
Remuzzi, G; Schieppati, A	2
Dai, SM; Fang, F; Shan, ZZ; Su, DF	1
Agarwal, R; Campbell, RC; Warnock, DG	1
Ruggenenti, P	1
Gallagher, G; Huang, Y; Hunyor, SN; Ikeda, Y; Jiang, L; Kawaguchi, O; Shirota, K; Yuasa, T; Zeng, B; Zheng, X	1
Bonnet, S; Marthan, R; Pauvert, O; Rousseau, E; Savineau, JP	1
Ergul, A; Fagan, SC; Hess, DC; Hohnadel, EJ; Pollock, DM	1
Gao, L; Patel, KP; Wang, W; Zhu, GQ; Zucker, IH	1
Dimayuga, CA; Homma, S; Jorde, UP; Katz, SD; Le Jemtel, TH; Rizkala, A; Vittorio, TJ	1
Ando, T; Itoh, M; Joh, T; Kuno, A; Masuda, K; Nakamura, S; Nomura, T; Ogawa, K; Ohara, H; Okamoto, T; Shirai, T; Tang, M; Yamada, T	1
Allessie, M; Blaauw, Y; Eijsbouts, S; Neuberger, HR; Schotten, U; van Hunnik, A; Verheule, S	1
Campo, C; Ruilope, LM; Segura, J	1
Ritz, E; Wolf, G	1
Callera, GE; He, Y; Javeshghani, D; Lochard, N; Mercure, C; Reudelhuber, TL; Touyz, RM; Yao, G; Yogi, A	1
Couture, R; de Champlain, J; El Midaoui, A; Ongali, B; Petcu, M	1
Chaitman, BR; Friedman, JB; Ivleva, AY; Lawrence, JH; Lenis, JH; Pangerl, AM; Reisin, LH; Stieber, DM; Toth, C; Ujda, M	1
Czuriga, I	1
Wolf, G	1
Arbolishvili, GN; Baklanova, NA; Belenkov, IuN; Mareev, VIu; Nasonova, SN; Skvortsov, AA; Sychev, AV	1
Ahn, KO; Bang, BK; Choi, BS; Kim, J; Kim, JS; Kim, JY; Kim, YS; Li, C; Lim, SW; Yang, CW; Yang, HJ	1
Kida, Y	1
Bech, JN; Jensen, P; Nyvad, O; Pedersen, EB; Starklint, J	1
Baklanova, NA; Belenkov, IuN; Mareev, VIu; Masenko, VP; Nasonova, SN; Orlova, IaA; Skvortsov, AA; Sychev, AV	1
Lim, H; Zhu, YZ	1
Zucker, IH	1
Elmarakby, AA; Imig, JD; Pollock, DM; Pollock, JS; Williams, JM	1
Cohn, JN	1
Wynn, TA	1
Aro, J; Ruskoaho, H; Rysä, J	1
Belardinelli, R	1
Cooper, SA; Habibi, J; Lastra, G; Manrique, C; Sowers, JR; Stas, S; Wei, Y; Whaley-Connell, A	1
Adrogue, HJ; Huang, XR; Lan, HY; Soltero, L; Wang, W; Zhang, P	1
Anderson, NR; Cornish, KG; Hackley, JF; Hiser, BA; Irwin, ED; Kieval, R; Peuler, JD; Rossing, MA; Serdar, DJ; Zucker, IH	1
Kobori, H; Nangaku, M; Navar, LG; Nishiyama, A	1
Bobillier, A; Gardner, R; Hillier, C; MacFadyen, R; Mann, J; McDonagh, T; McMurray, J; Murdoch, D; Seed, A	1
Cornish, KG; Liu, D; Mousa, TM; Zucker, IH	1
Middlekauff, HR; Negrão, CE	1
Aranha, AB; Callera, GE; Mercure, C; Montezano, AC; Reudelhuber, T; Tostes, RC; Touyz, J; Touyz, RM; Yogi, A	1
Egawa, T; Hanafusa, N; Kawasaki, H; Mio, M; Takatori, S; Yabumae, N; Zamami, Y	1
Fink, GD; King, AJ; Novotny, M; Swain, GM	1
Sullivan, JC	1
Bíbová, J; Hampl, V; Herget, J; Jakoubek, V	1
Higuchi, R; Miyawaki, M; Okutani, T; Yoshikawa, N	1
Fujita, T; Nangaku, M	1
Hayashi, M; Kitajima, W; Saruta, T	1
Espiner, EA; Fitzpatrick, D; Ikram, H; Nicholls, MG	1
Augustin, HJ; Huland, H; Leichtweiss, HP	1
Worley, RJ	1
Amery, A; Billiet, L; Fagard, R; Lijnen, P; Reybrouck, T	1
Cody, RJ; Covit, AB; Laragh, JH; Schaer, GL	1
Punzengruber, C; Silberbauer, K; Sinzinger, H	1
Beretta-Piccoli, C; Reubi, FC; Schiffl, H; Weidmann, P	1
Binetti, G; Branzi, A; Lolli, C; Magnani, B; Piovaccari, G; Rapezzi, C; Specchia, S; Zannoli, R	1
Bing, RF; Mistry, M; Swales, JD; Thurston, H	1
Dietz, R; Ganten, D; Mann, JF; Ritz, E	1
Mareev, VIu	1
James, OF; Robson, V; Sellars, L; Shore, AC; Wilkinson, R	1
Bing, RF; Marks, ES; Swales, JD; Thurston, H	1
Boiadzhan, PP; Kutsenko, AI; Levitskaia, IuV; Shapkina, LS; Shpil'kin, VM	1
Bahlmann, J; Brod, J; Cachovan, M; Hubrich, W; Pretschner, D	1
Bonomini, V; Feletti, C; Scolari, MP; Stefoni, S; Vangelista, A	1
Chen, WY; Hsieh, BS; Tsai, TJ; Yen, TS	1
Kubo, S; Nishimura, H; Nishioka, A; Sonotani, N; Takatsu, T	1
Cruz-Hernandez, JJ; Diez-Jarilla, JL; Laso, FJ; Pino, J	1
Aizawa, Y; Hirasawa, Y; Imai, K; Sakai, S; Tajiri, M	1
Gnüchtel, U; Krasil'nikov, VG; Nichkov, S; Zeschke, G	1
Aizawa, Y; Kobayashi, N; Obata, N; Ohta, T; Shibata, A; Watanabe, K	1
Haudenschild, CC; Jacobs, AK; Landau, C	1
Bellamy, CM; Dodds, PA; Muirhead, RA; Perry, RA	1
Angus, RM; Connell, JM; Hulks, G; Millar, EA; Morton, JJ; Thomson, NC	1
Komissarenko, IV; Markov, VV; Oleĭnik, VA; Rudichenko, VM; Slavnov, VN	1
Andreotti, F; Bradshaw, A; Cleland, JG; Oakley, CM; Sbarouni, E; Tuddenham, E	1
Kline, RL; van der Mark, J	1
Baker, PN; Broughton Pipkin, F	1
Ageev, FT; Belenkov, IuN; Dzhakhangirov, TSh; Gkhani, P; Lopatin, IuM; Mareev, VIu	1
Goldsmith, SR; Hasking, GJ; Miller, E	1
Asakuma, S; Fujiwara, M; Iwasaki, T; Nakamura, K; Nakamura, T	1
Matsuo, H	1
Balcells, E; Bishop, SP; Cartee, RE; Dell'Italia, LJ; Dillon, R; Hankes, GH; Meng, QC; Oparil, S; Orr, R; Straeter-Knowlen, IM	1
Iijima, Y; Ishigooka, M; Kubota, Y; Nakada, T; Suzuki, H; Watanabe, M	1
Blaine, EH; Dale, WE; Hasser, EM; Li, Q	1
Abe, K; Jiang, ZL; Johnston, CI; Kamimoto, M; Kanazawa, M; Kohzuki, M; Sato, T; Wu, XM; Yasujima, M; Yoshida, K	1
Aliot, E; Chati, Z; Mertès, PM; Zannad, F	1
Bertani, T; Colosio, V; Corna, D; Donadelli, R; Facchinetti, D; Luzzana, E; Maffi, R; Remuzzi, G; Testa, D; Zoja, C	1
Granger, J; Pigg, K; Schnackenberg, C; Tucker, B	1
Casarini, D; dos Santos, OF; Monte, JC; Parise, E; Schor, N	1
Anderson, WP; Evans, RG; Fitzgerald, SM; Stevenson, KM	1
Armengol, NE; Bono Illa, M; Calls Ginesta, J; Cases Amenós, A; Gaya Bertrán, J; Rivera Fillat, FR	1
Barr, CS; Fenwick, M; MacFadyen, RJ; Struthers, AD; Sturrock, ND	1
Huang, WQ; Qian, ZM; Tang, PL; Xiao, DS; Xu, B	1
Aguilar, M; Andujar, M; Arrebola, F; del Moral, RG; García-Chicano, MJ; Gómez-Morales, M; Guillén, M; Masseroli, M; Nogales, FF; O'Valle, F; Olmo, A; Ramírez, C	1
Kohan, DE	1
Camara, AK; Osborn, JL	2
Abe, I; Fujishima, M; Kagiyama, S; Liu, Y; Matsumura, K; Tsuchihashi, T	1
Amadesi, S; Calò, G; Mascoli, F; Quaglio, D; Regoli, D; Rizzi, A; Vasquez, G; Zamboni, P	1
Fang, TC; Huang, WC	1
Fitts, DA; Lane, JR; Li, CP; Starbuck, EM	1
Liu, JL; Zucker, IH	1
Campistol, JM; Clesca, PH; Iñigo, P; Jimenez, W; Lario, S; Oppenheimer, F; Rivera, F	1
Bao, G; Fletcher, EC; Li, R	1
Sham, JS; Shimoda, LA; Sylvester, JT	1
Domínguez, J; García-Escribano, JR; Paule, A; Rodríguez-García, JL; Vázquez, M	1
Willenheimer, R	1
Ezan, E; Fraser, C; Junot, C; MacFadyen, R; Morton, JJ; Robson, J; Struthers, AD	1
Farquharson, CA; Struthers, AD	2
Brenner, BM; Taal, MW	1
Just, H	1
Bianchetti, MG; Teuffel, O; von Vigier, RO; Zberg, PM	1
Bulagannawar, M; Carretero, OA; Cavasin, MA; Karumanchi, R; Liu, YH; Mehta, D; Yang, XP	1
Iwao, H; Izumi, Y; Kim, S; Namba, M; Yasumoto, H; Zhan, Y	1
Henger, A; Hulter, HN; Krapf, R; Riesen, WF; Tutt, P	1
Cestari, IA; Farah, VM; Irigoyen, MC; Krieger, EM; Moreira, ED; Ushizima, M	1
Fung, ML; Leung, PS; Sernia, C	1
Fung, ML; Lam, SY; Leung, PS	1
Leenen, FH; Zhang, J	1
Galli, SM; Kagiyama, S; Phillips, MI; Varela, A	1
Fowler, MB; Jamali, AH; Khot, UN; Tang, WH	1
Martínez-Maldonado, M	1
Belus, A; Bonnet, S; Hyvelin, JM; Marthan, R; Roux, E; Savineau, JP	1
Burroughs, AK; Patch, D; Tang, AK; Vlachogiannakos, J	1
Gaffney, FA; Ichihara, S; Ichiki, T; Inagami, T; Price, E; Senbonmatsu, T	1
Liu, JL; Patel, KP; Pliquett, RU; Wang, W; Zucker, IH	1
Maki, T; Nasa, Y; Takahashi, M; Takeo, S; Tanonaka, K; Yoshida, H	1
Connell, JM; Hillier, C; McDonald, JE; McMurray, JJ; Padmanabhan, N; Petrie, MC	1
Date, Y; Hosoda, H; Kangawa, K; Koh, H; Kojima, M; Nagaya, N; Nakazato, M; Okumura, H; Oya, H; Shimizu, W; Uematsu, M; Yamagishi, M; Yutani, C	1
Cachat, F; Chevalier, RL	1
Faúndez, P; Jalil, JE; Lavandero, S; Ocaranza, MP; Piddo, AM	1
Hanon, S; Le Jemtel, TH; Sonnenblick, EH; Vijayaraman, P	1
Guo, Z; Lai, W; Li, J; Li, S; Liu, Y; Wu, P; Xiu, JC; Xu, JP; Zhang, Y	1
Pollock, DM; Pollock, JS; Sasser, JM	1
Hayashi, K; Honda, M; Kubota, E; Matsuda, H; Okubo, K; Ozawa, Y; Saruta, T; Takamatsu, I; Tatematsu, S; Tokuyama, H; Wakino, S	1
Gant, NF; Worley, RJ	1
Lieberman, J	1
Loyke, HF	1
Kokot, F	1
Davis, JO	1
Postnov, IuV	1
Cagossi, M; Pigliucci, GM; Porcelli, G; Ruvolo, MR	1
Bannester, R; Davies, B; Sever, P; Wilcox, C	1
Carretero, OA; Gulati, OP	1
Cardona, R; Huang, CT; Michelakis, AM	1
Bailey, RR; Little, PJ; Maling, TM; McRae, CU; Tisch, G	1
Rachinskiĭ, ID	1
Balfe, JW; Guyton, AC; Hall, JE; McCaa, RE; Salgado, HC	1
Cowley, AW; Lohmeier, TE	1
Chand, S; Gant, NF; Jimenez, JM; MacDonald, PC; Whalley, PJ	1
Ayers, CR; Carey, RM; Katholi, RE; Kimbrough, HM; Morton, CL; Vaughan, ED; Yancey, MR	1
Gillenwater, JY; Moody, TE; Vaughan, ED; Wyker, AT	1
Dluhy, RG; Hollenberg, NK; Mersey, JH; Williams, GH	1
Farber, MO; Kiblawi, SS; Manfredi, F; Robertson, GL; Strawbridge, RA; Weinberger, MH	1
Anderson, GH; Goldman, SH; Schroeder, ET; Streeten, DH	1
Bernheim, JL; Myers, BD; Pokroy, N	1
Ledingham, JM	2
Peart, WS	1
Kajiwara, N	1
Lee, KE; Romero, JC; Schryver, SM; Strong, CG; Wilson, DM	1
Shushliapin, OI; Vlasenko, MA	1
Kravchun, PG; Mikliaev, IIu; Rachinskiĭ, ID; Shushliapin, OI; Vlasenko, MA	1
Schölkens, BA	1
Packer, M	1
Matthews, A; Peacock, AJ	1
Beermann, B; Cederholm, T; Hildebrand, IL; Jansson, E; Sylvén, C	1
Clarke, NW; George, NJ; Jones, DA; Laing, I; Tames, F	1
Caramelo, C; Hernando, L; López-Novoa, JM; Olivera, A; Velo, M; Villamediana, LM	1
Doyle, MP; Walker, BR	1
Coleman, TG; Hall, JE; Mizelle, HL; Smith, MJ	1
Fujioka, H; Hada, T; Higashino, K; Iwahashi, N; Maeda, J; Nakano, T; Tamura, S; Yamamoto, T	1
Cody, RJ	1
Basso, N; Martin, IH; Sarchi, MI; Taquini, AC	1
Barrett, J; Eggena, P; Trujillo, A; Tuck, M	1
Harrison, GL; McMurtry, IF; Moore, LG	1
Coleman, TG; Hall, JE; Mizelle, HL	1
Lohmeier, TE; Montani, JP; Rushing, EL; Smith, MJ	1
Eiskjaer, H; Jespersen, B; Pedersen, EB; Rasmussen, LM	1
Danielsen, H; Pedersen, EB	2
Danielsen, H; Pedersen, EB; Sørensen, SS	1
Esser, H; Heck, I; Kikis, D; Stumpe, KO	1
Jackson, RM; Narkates, AJ; Oparil, S	1
Christensen, NJ; Danielsen, H; Pedersen, EB	1
Jackson, EK; Robertson, D; Zimmerman, JB	1
Maruyama, K; Mullen, M; O'Brodovich, H; Olley, PM; Rabinovitch, M; Rosenberg, HC	1
Danielsen, H; Jespersen, B; Pedersen, EB	1
Blantz, RC; Mundy, CA; Tucker, BJ	1
Dzau, VJ; Gibbons, GH; Nabel, EG	1
Abe, H; Fujiwara, Y; Miki, S; Orita, Y; Sasaki, E; Takamitsu, Y	1
Kiseleva, ZM; Serebrovskaia, IuA; Uchitel', IA	1
Waite, MA	1
Pasternack, A	1
Bumpus, FM; Sen, S; Smeby, RR	1
de Jong, W	1
Bourgoignie, J; Catanzaro, F; Perry, HM; Serirat, P	1
Enescu, E; Grosu, L; Uza, G	1
Mertz, DP	1
Brown, H; Deleña, S; Fleischer, N; Graham, DY	1
Fregnan, GB	1
Hattori, N; Katsuki, S; Omae, T; Tanaka, K	1
Okano, M	1
Fukuda, T; Honda, H; Kobayashi, H; Miyama, S; Tanaka, T	1
Barjon, P	1
Albrecht, KF; Eigler, FW; Heinecke, G; Marquardt, H; Sologuren, D	1
Markov, KhM	1
Baumber, JS; Davis, JO; Johnson, JA; Schneider, EG	1
Alvisi, R; Baggioni, GF; Ripa, R; Salzano, S	1
Bollinger, A	1
Fukiyama, K; McCubbin, JW; Page, IH	1
Schirmeister, J	1
Cottier, P; Reubi, F; Veyrat, R; Wettstein, R	1
Commichau, R; Koch, HG; Thienemann, V	1
Feldner, H; Giessauf, W; Kratochvil, K; Pogglitsch, H; Stöckl, G	1
Dabels, J; Kochan, E; Sievers, P; Wendel, H	1
Chkalova, IP; Paleeva, FM; Serebrovskaia, IuA; Uchitel', IA	1
Isakova, ZS; Loginov, AS; Serebrovskaia, IuA; Uchitel', IA	1
Fujii, J; Kuramochi, M; Seki, A; Yazaki, Y	1
Bell, PR; Briggs, JD; Brown, JJ; Fine, A; Lever, AF; Medina, A; Morton, JJ; Paton, AM; Robertson, JI; Tree, M; Waite, MA; Weir, R; Winchester, J	1
Fukuchi, S; Takeuchi, T; Torikai, T	1
Koletsky, S	1
Kukes, VG; Men'shikov, VV; Sivkov, II	1
Bologna, E; Bossini, A	1
Jahnecke, J	1
Köhler, M	1
Kinoshita, M; Kusukawa, R	1
Kuntz, E	1
Kohl, PV; Rothenberger, W; Siemensen, HC; Sill, V; Voelkel, N	1
Kaneko, Y	1
Kondo, K; Matsuki, S; Nakamura, R; Saito, I; Saruta, T	1
Hoobler, SW; Mak, SW; Romero, JC	1
Davis, JO; Freeman, RH; Johnson, JA; Spielman, WS	1
de Portugal, J; Perezagua, C; Velasco, A	1
Galla, SJ; Leenen, FH; McDonald, RH; Redmond, DP; Shapiro, AP; Vagnucci, AH	1
Barnes, GE; Coleman, TG; Cowley, AW; DeClue, JW; Fagard, R; Guyton, AC; Langford, HG; McCaa, RE	1
Kaneko, Y; McCubbin, JW; Page, IH	1

Reviews

61 review(s) available for angiotensin ii and Chronic Disease

Article	Year
Pathways of hepatic and renal damage through non-classical activation of the renin-angiotensin system in chronic liver disease. Liver international : official journal of the International Association for the Study of the Liver, 2020, Volume: 40, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Humans; Kidney Tubules, Proximal; Liver Diseases; Renin-Angiotensin System; Sodium	2020
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Role of angiotensin II in chronic intermittent hypoxia-induced hypertension and cognitive decline. American journal of physiology. Regulatory, integrative and comparative physiology, 2021, 04-01, Volume: 320, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Chronic Disease; Cognition; Cognitive Dysfunction; Humans; Hypertension; Hypoxia; Renin-Angiotensin System; Risk Factors; Signal Transduction; Sleep Apnea Syndromes	2021
Angiotensin II and skeletal muscle abnormalities. Experimental physiology, 2017, 06-01, Volume: 102, Issue:6 Topics: Angiotensin I; Angiotensin II; Animals; Chronic Disease; Exercise; Humans; Muscle, Skeletal; Weight Loss	2017
Brain Angiotensin II Involvement in Chronic Mental Disorders. Protein and peptide letters, 2017, Nov-17, Volume: 24, Issue:9 Topics: Angiotensin II; Animals; Chronic Disease; Humans; Mental Disorders; Molecular Targeted Therapy; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1	2017
Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 94 Topics: Acute Disease; Angiotensin II; Chronic Disease; Homeostasis; Humans; Inflammation; Renin; Renin-Angiotensin System	2017
Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling. Circulation research, 2018, 01-19, Volume: 122, Issue:2 Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cardiovascular Diseases; Chronic Disease; Chymases; Enzyme Inhibitors; Humans; Mast Cells; Renin-Angiotensin System; Vascular Remodeling	2018
Chronic heart failure: a disease of the brain. Heart failure reviews, 2019, Volume: 24, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Baroreflex; Brain; Cardiomegaly; Chronic Disease; Heart; Heart Failure; Humans; Inflammation; Natriuretic Peptide, Brain; Neuroimmunomodulation; Norepinephrine; Oxidative Stress; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Renin-Angiotensin System; Sympathetic Nervous System; Vagus Nerve Stimulation	2019
The effect of taurine on chronic heart failure: actions of taurine against catecholamine and angiotensin II. Amino acids, 2014, Volume: 46, Issue:1 Topics: Angiotensin II; Animals; Catecholamines; Chronic Disease; Heart Failure; Humans; Renin-Angiotensin System; Taurine	2014
The renin-angiotensin-aldosterone system and heart failure. Cardiology clinics, 2014, Volume: 32, Issue:1 Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiotensin System; Treatment Outcome; Ventricular Remodeling	2014
Central mechanisms for exercise training-induced reduction in sympatho-excitation in chronic heart failure. Autonomic neuroscience : basic & clinical, 2015, Volume: 188 Topics: Angiotensin II; Brain; Chronic Disease; Exercise Therapy; Heart Failure; Humans; Nitric Oxide; Oxidative Stress; Quality of Life; Sympathetic Nervous System	2015
Current and future anti-fibrotic therapies for chronic liver disease. Clinics in liver disease, 2008, Volume: 12, Issue:4 Topics: Angiotensin II; Chronic Disease; Colchicine; Collagen; Extracellular Matrix; Hepatic Stellate Cells; Humans; Interferon-gamma; Ligands; Liver Cirrhosis; PPAR gamma; Pyridones	2008
Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure. American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:5 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Chronic Disease; Exercise; Heart; Heart Failure; Humans; Medulla Oblongata; Neurons; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Signal Transduction; Sympathetic Nervous System; Transcription Factor AP-1; Transcription, Genetic; Up-Regulation	2009
Direct Renin inhibition: promising treatment in renoprotection? Recent patents on cardiovascular drug discovery, 2010, Volume: 5, Issue:2 Topics: Amides; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Fumarates; Humans; Kidney Diseases; Rats; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Treatment Outcome	2010
Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Current opinion in pharmacology, 2011, Volume: 11, Issue:2 Topics: Angiotensin II; Angiotensinogen; Animals; Chronic Disease; Humans; Hypertension; Kidney; Kidney Tubules, Collecting; Prorenin Receptor; Receptors, Cell Surface; Renin	2011
Coupling between respiratory and sympathetic activities as a novel mechanism underpinning neurogenic hypertension. Current hypertension reports, 2011, Volume: 13, Issue:3 Topics: Angiotensin II; Chronic Disease; Humans; Hypertension; Hypoxia; Pressoreceptors; Respiratory System; Sympathetic Nervous System; Time Factors	2011
Therapeutic vaccines for chronic diseases: successes and technical challenges. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2011, Oct-12, Volume: 366, Issue:1579 Topics: Angiotensin II; Animals; Antibodies; Antibody Formation; Antihypertensive Agents; Chronic Disease; Diabetes Mellitus, Type 2; Humans; Hypertension; Interleukin-1beta; Mice; Nicotine; Risk Factors; Smoking; Smoking Cessation; Vaccination; Vaccines; Vaccines, Virus-Like Particle	2011
[Role of chronic inflammation in the pathogenesis of atherosclerosis]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2011, Volume: 138, Issue:5 Topics: Adipokines; Adipose Tissue; Angiotensin II; Animals; Atherosclerosis; Chronic Disease; Coronary Vessels; Cytokines; Humans; Inflammation; Inflammation Mediators; Life Style; Macrophages; Neovascularization, Pathologic; Plaque, Atherosclerotic; Vascular Endothelial Growth Factor A	2011
The role of angiotensin II in nonalcoholic steatohepatitis. Molecular and cellular endocrinology, 2013, Sep-25, Volume: 378, Issue:1-2 Topics: Angiotensin II; Animals; Chronic Disease; Fatty Liver; Humans; Insulin Resistance; Liver Cirrhosis; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Renin-Angiotensin System; Signal Transduction	2013
Angiotensin II, sympathetic nerve activity and chronic heart failure. Heart failure reviews, 2014, Volume: 19, Issue:2 Topics: Angiotensin II; Chronic Disease; Heart; Heart Failure; Humans; Sympathetic Nervous System	2014
The renin-angiotensin system in progression, remission and regression of chronic nephropathies. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 2002, Volume: 20, Issue:3 Topics: Angiotensin II; Animals; Chronic Disease; Humans; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Proteins; Renin-Angiotensin System	2002
Proteinuria and its consequences in renal disease. Acta paediatrica (Oslo, Norway : 1992). Supplement, 2003, Volume: 92, Issue:443 Topics: Angiotensin II; Chronic Disease; Disease Progression; Fabry Disease; Humans; Hyperlipidemias; Hypertension, Renal; Hypertrophy; Kidney Diseases; Kidney Glomerulus; Proteinuria	2003
Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II. Seminars in nephrology, 2004, Volume: 24, Issue:2 Topics: Angiotensin II; Animals; Cells, Cultured; Chronic Disease; Disease Models, Animal; Humans; Hypertension; Infusion Pumps; Kidney Diseases; Oxidative Stress; Sodium Chloride, Dietary	2004
Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies. Seminars in nephrology, 2004, Volume: 24, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Chronic Disease; Drug Therapy, Combination; Humans; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Remission Induction	2004
Targets for vascular protection after acute ischemic stroke. Stroke, 2004, Volume: 35, Issue:9 Topics: Acute Disease; Angiopoietins; Angiotensin II; Antioxidants; Apoptosis; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Cerebral Arteries; Cerebral Hemorrhage; Chronic Disease; Endothelin-1; Endothelium, Vascular; Humans; Inflammation Mediators; Matrix Metalloproteinases; Neuroprotective Agents; Neutrophils; Oxidative Stress; Reactive Oxygen Species; Vascular Endothelial Growth Factor A; Vasculitis	2004
Influence of chronic kidney disease development and renin-angiotensin system inhibition on cardiovascular prognosis. Current medicinal chemistry. Cardiovascular and hematological agents, 2005, Volume: 3, Issue:1 Topics: Angiotensin II; Cardiovascular Diseases; Chronic Disease; Creatinine; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Kidney Diseases; Male; Prognosis; Renin-Angiotensin System; Risk Factors	2005
Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney international, 2005, Volume: 67, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Drug Therapy, Combination; Humans; Kidney; Kidney Diseases; Receptors, Angiotensin; Renin-Angiotensin System	2005
[Chronic heart failure--the epidemic of the 21st century]. Orvosi hetilap, 2005, May-15, Volume: 146, Issue:20 Suppl 2 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Defibrillators, Implantable; Digitalis Glycosides; Diuretics; Endothelin Receptor Antagonists; Erythropoietin; Heart Failure; Heart-Assist Devices; Humans; Hungary; Immunologic Factors; Mineralocorticoid Receptor Antagonists; Pacemaker, Artificial; Peptide Hydrolases; Primary Prevention; Risk Factors; Severity of Illness Index; Vasopressins	2005
[The renin-angiotensin-aldosterone system -- more complex as previously thought]. Medizinische Klinik (Munich, Germany : 1983), 2005, Aug-15, Volume: 100, Issue:8 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Chymases; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Humans; Indoles; Kidney Diseases; Kidney Tubules, Proximal; Losartan; Prospective Studies; Receptors, Angiotensin; Renin-Angiotensin System; Risk Factors; Serine Endopeptidases	2005
Role of transforming growth factor-beta in the progression of heart failure. Cellular and molecular life sciences : CMLS, 2006, Volume: 63, Issue:22 Topics: Angiotensin II; Animals; Cardiac Output, Low; Chronic Disease; Disease Progression; Heart Diseases; Humans; Myocardium; Signal Transduction; Transforming Growth Factor beta; Ventricular Remodeling	2006
Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension (Dallas, Tex. : 1979), 2006, Volume: 48, Issue:6 Topics: Angiotensin II; Animals; Baroreflex; Central Nervous System; Chronic Disease; Heart Failure; Humans; Oxidative Stress; Reactive Oxygen Species; Reflex; Renin-Angiotensin System; Sympathetic Nervous System	2006
Rationale for angiotensin II receptor blocker therapy in chronic heart failure. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2000, Volume: 1, Issue:2 Suppl Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Chronic Disease; Heart Failure; Humans; Long-Term Care; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan	2000
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. The Journal of clinical investigation, 2007, Volume: 117, Issue:3 Topics: Angiotensin II; Cell Proliferation; Chronic Disease; Embryonic Stem Cells; Fibroblasts; Fibrosis; Humans; Infections; Neovascularization, Pathologic; Transforming Growth Factor beta1; Wound Healing	2007
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:4 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus, Type 2; Endothelium, Vascular; Humans; Hypertension; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Kidney Diseases; Metabolic Syndrome; Mineralocorticoids; Muscle, Skeletal; Myocardium; Oxidative Stress; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Factors; Signal Transduction	2007
The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacological reviews, 2007, Volume: 59, Issue:3 Topics: Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Chronic Disease; Disease Models, Animal; Humans; Hypertension; Hypertension, Renal; Kidney; Kidney Diseases; Receptors, Angiotensin; Renin; Renin-Angiotensin System	2007
Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition. American journal of physiology. Regulatory, integrative and comparative physiology, 2008, Volume: 294, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Estradiol; Female; Humans; Kidney; Kidney Diseases; Male; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sex Factors; Signal Transduction; Treatment Outcome	2008
Activation of the renin-angiotensin system and chronic hypoxia of the kidney. Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:2 Topics: Angiotensin II; Animals; Chronic Disease; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Kidney Diseases; Kidney Failure, Chronic; Microcirculation; Oxidative Stress; Renal Circulation; Renin-Angiotensin System	2008
[Use of captopril in circulatory failure]. Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR, 1982, Volume: 5, Issue:2 Topics: Angiotensin II; Animals; Captopril; Chronic Disease; Drug Evaluation; Heart Failure; Hemodynamics; Humans; Proline; Renin; Renin-Angiotensin System	1982
[Clinical evaluation of ACE inhibitors for therapy of chronic congestive heart failure]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1995, Sep-10, Volume: 84, Issue:9 Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Chronic Disease; Clinical Trials as Topic; Coronary Circulation; Heart Failure; Humans; Middle Aged; Renin; Ultrasonography	1995
Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney international, 2000, Volume: 57, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Drug Therapy, Combination; Humans; Kidney; Kidney Diseases; Proteinuria; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2	2000
[Therapy for heart failure]. Therapeutische Umschau. Revue therapeutique, 2000, Volume: 57, Issue:5 Topics: Acute Disease; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Cardiotonic Agents; Chronic Disease; Diuretics; Heart Failure; Humans; Vasodilator Agents	2000
The role of angiotensin receptor blockers in the management of chronic heart failure. Archives of internal medicine, 2001, Mar-12, Volume: 161, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Chronic Disease; Clinical Trials as Topic; Forecasting; Heart Failure; Humans; Losartan	2001
Role of hypertension in the progression of chronic renal disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16 Suppl 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Black or African American; Black People; Chronic Disease; Disease Progression; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Muscle, Smooth, Vascular; United States	2001
Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease. Gut, 2001, Volume: 49, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Chronic Disease; Glomerular Filtration Rate; Humans; Hypertension, Portal; Liver Cirrhosis; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Sodium	2001
The regulation of sympathetic outflow in heart failure. The roles of angiotensin II, nitric oxide, and exercise training. Annals of the New York Academy of Sciences, 2001, Volume: 940 Topics: Angiotensin II; Animals; Cardiac Output, Low; Chronic Disease; Endothelin-1; Nitric Oxide; Physical Conditioning, Animal; Sympathetic Nervous System	2001
Role of angiotensin II in chronic ureteral obstruction. Contributions to nephrology, 2001, Issue:135 Topics: Angiotensin II; Animals; Chronic Disease; Humans; Kidney Diseases; Prognosis; Rats; Renin-Angiotensin System; Risk Assessment; Risk Factors; Ureteral Obstruction	2001
Persistent formation of angiotensin II despite treatment with maximally recommended doses of angiotensin converting enzyme inhibitors in patients with chronic heart failure. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2000, Volume: 1, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; Chronic Disease; Dose-Response Relationship, Drug; Humans; Randomized Controlled Trials as Topic	2000
The pathogenesis of chronic renovascular hypertension. Circulation research, 1977, Volume: 40, Issue:5 Topics: Angiotensin II; Animals; Body Fluids; Cardiac Output; Chronic Disease; Disease Models, Animal; Homeostasis; Humans; Hypertension, Renal; Kallikreins; Kidney Medulla; Kinins; Muscle, Smooth; Prostaglandins A; Prostaglandins E; Renal Artery Obstruction; Renin; Sympathetic Nervous System; Transplantation, Autologous; Transplantation, Homologous	1977
[Kidney in chronic arterial hypertension: "resetting" and the role of the renal medulla in its development]. Kardiologiia, 1979, Volume: 19, Issue:12 Topics: Angiotensin II; Animals; Arterioles; Blood Pressure; Chronic Disease; Diuresis; Homeostasis; Humans; Hypertension; Hypertrophy; Kidney; Kidney Medulla; Kidney Tubules; Natriuresis; Nephrosclerosis; Renin; Vascular Resistance	1979
Experimental renal hypertension. Clinical nephrology, 1975, Volume: 4, Issue:4 Topics: Acute Disease; Angiotensin II; Animals; Autonomic Nervous System; Body Fluids; Chronic Disease; Constriction; Heart; Hemodynamics; History, 20th Century; Humans; Hypertension, Renal; Kidney; Myocardium; Nephrectomy; Neurons, Efferent; Plasma Volume; Pressoreceptors; Renal Artery; Renin; Sodium; Vascular Resistance; Vasomotor System	1975
The place of renin in the mechanism of hypertension in chronic renal disease. Clinical nephrology, 1975, Volume: 4, Issue:4 Topics: Angiotensin II; Animals; Chronic Disease; History, 19th Century; History, 20th Century; Humans; Hypertension, Renal; Kidney Diseases; Kidney Neoplasms; Radioimmunoassay; Renal Artery Obstruction; Renin	1975
Pathophysiology of chronic heart failure. Lancet (London, England), 1992, Jul-11, Volume: 340, Issue:8811 Topics: Angiotensin II; Catecholamines; Chronic Disease; Energy Metabolism; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Neurosecretory Systems; Sodium; Vasoconstriction	1992
Pathophysiology of experimental renovascular hypertension. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1985, Volume: 5, Issue:4 Topics: Acute Disease; Angiotensin II; Animals; Arterial Occlusive Diseases; Central Nervous System; Chronic Disease; Disease Models, Animal; Dogs; Hemodynamics; Hypertension, Renovascular; Kidney; Ouabain; Perfusion; Rats; Renin-Angiotensin System; Sympathetic Nervous System; Vasoconstriction; Vasopressins	1985
["Hypertensive vascular changes" with and without hypertension]. Nordisk medicin, 1969, Jul-19, Volume: 82, Issue:28 Topics: Angiotensin II; Blood Vessels; Chronic Disease; Diarrhea; Female; Humans; Hyalin; Hyperaldosteronism; Hyperplasia; Hypertension; Hypertension, Malignant; Hypertrophy; Male; Necrosis; Nephrotic Syndrome; Renin; Vomiting	1969
[Renovascular hypertension in pregnancy]. Naika. Internal medicine, 1969, Volume: 24, Issue:4 Topics: Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Female; Humans; Hypertension, Renal; Kidney; Kidney Diseases; Norepinephrine; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Renin; Time Factors; Vasopressins	1969
[Neurogenic mechanisms in the pathogenesis of renal hypertension]. Vestnik Akademii meditsinskikh nauk SSSR, 1970, Volume: 25, Issue:1 Topics: Acute Disease; Angiotensin II; Animals; Cats; Cerebrovascular Circulation; Chronic Disease; Denervation; Dogs; Higher Nervous Activity; Hypertension, Renal; Ischemia; Ischemic Attack, Transient; Kidney; Norepinephrine; Pressoreceptors; Rabbits; Rats; Spinal Cord; Sympathectomy; Sympathetic Nervous System	1970
[Physiopathology of renal hypertension]. Medizinische Klinik, 1970, Jun-26, Volume: 65, Issue:26 Topics: Adult; Aldosterone; Angiotensin II; Animals; Chronic Disease; Dogs; Humans; Hypertension, Renal; Nephrectomy; Prognosis; Regional Blood Flow; Renal Artery; Renal Veins; Renin; Sodium; Water-Electrolyte Balance	1970
[The renin-angiotensin system in patients with cirrhosis of the liver]. Terapevticheskii arkhiv, 1971, Volume: 43, Issue:12 Topics: Angiotensin II; Ascites; Chronic Disease; Endopeptidases; Hepatitis A; Humans; Hypertension; Liver Cirrhosis; Renin	1971
The role of renal factors in the pathogenesis of experimental hypertension. International review of experimental pathology, 1973, Volume: 12 Topics: Aldosterone; Angiotensin II; Animals; Cadmium; Cattle; Chronic Disease; Embolism; Glomerulonephritis; Hypertension; Hypertension, Renal; Infarction; Ischemia; Kidney; Kidney Transplantation; Nephrectomy; Prostaglandins; Pyelonephritis; Renal Artery; Renin; Sodium Chloride; Transplantation, Homologous	1973
[Hepatogenous (secondary) aldosteronism (author's transl)]. MMW, Munchener medizinische Wochenschrift, 1974, May-17, Volume: 116, Issue:20 Topics: Aldosterone; Angiotensin II; Chronic Disease; Esophageal and Gastric Varices; Hepatitis; Hepatitis A; Humans; Hyperaldosteronism; Liver Diseases; Liver Function Tests; Portacaval Shunt, Surgical; Renin; Spironolactone; Water; Water-Electrolyte Balance	1974
[Review on internal medicine, 1973--nephrology. 5. The renin-angiotensin system (author's transl)]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1974, Apr-10, Volume: 63, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cerebrovascular Disorders; Chronic Disease; Glomerulonephritis; Humans; Hypertension; Hypertension, Malignant; Hypertension, Renal; Propranolol; Renin	1974

Trials

26 trial(s) available for angiotensin ii and Chronic Disease

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial. Transplantation, 2014, May-27, Volume: 97, Issue:10 Topics: Allografts; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Atrophy; Biopsy; Chronic Disease; Creatinine; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Hyperuricemia; Kidney Failure, Chronic; Kidney Transplantation; Kidney Tubules; Male; Middle Aged; Nephritis, Interstitial; Treatment Outcome; Uric Acid	2014
[Effect of loop diuretics with different elimination half-lives on natriuresis changes and indicators characterizing the state of renal tubulointerstitial tissue]. Terapevticheskii arkhiv, 2014, Volume: 86, Issue:6 Topics: Adult; Angiotensin II; Chronic Disease; Delayed-Action Preparations; Female; Half-Life; Heart Failure; Humans; Hypertension; Kidney Tubules; Male; Middle Aged; Natriuresis; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide	2014
[Plasma tissue factor and serum angiotensin II and the therapeutic effect of different dosages of fosinopril on chronic heart failure]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2009, Volume: 34, Issue:5 Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Fosinopril; Heart Failure; Humans; Male; Middle Aged; Thromboplastin	2009
Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion. American journal of physiology. Renal physiology, 2012, Apr-15, Volume: 302, Issue:8 Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Aquaporin 2; Atrial Natriuretic Factor; Chronic Disease; Cross-Over Studies; Cyclic AMP; Dinoprostone; Epithelial Sodium Channels; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Polycystic Kidney, Autosomal Dominant; Renin; Saline Solution, Hypertonic; Sodium; Vasopressins; Young Adult	2012
Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure. Circulation, 2002, Aug-27, Volume: 106, Issue:9 Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chronic Disease; Enzyme Activation; Female; Heart Failure; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Radial Artery; Sodium, Dietary; Tonometry, Ocular; Treatment Outcome	2002
Vasopressor response to angiotensin II infusion in patients with chronic heart failure receiving beta-blockers. Circulation, 2003, Jan-21, Volume: 107, Issue:2 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Carbazoles; Carvedilol; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Metoprolol; Middle Aged; Propanolamines	2003
Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure. The American journal of cardiology, 2004, Dec-15, Volume: 94, Issue:12 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Double-Blind Method; Enalapril; Endothelium, Vascular; Exercise Tolerance; Female; Heart Failure; Humans; Indoles; Male; Middle Aged; Renin-Angiotensin System	2004
Antianginal efficacy of omapatrilat in patients with chronic angina pectoris. The American journal of cardiology, 2005, Jun-01, Volume: 95, Issue:11 Topics: Angina Pectoris; Angiotensin II; Angiotensin III; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Chronic Disease; Double-Blind Method; Exercise Tolerance; Female; Humans; Male; Middle Aged; Neprilysin; Pyridines; Thiazepines	2005
[Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect o Terapevticheskii arkhiv, 2005, Volume: 77, Issue:8 Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Quinapril; Renin; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan	2005
Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure. Scandinavian journal of clinical and laboratory investigation, 2006, Volume: 66, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Aquaporin 2; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Cross-Over Studies; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Male; Middle Aged; Natriuresis; Natriuretic Peptide, Brain; Renin	2006
[Effects of long term therapy with angiotensin converting enzyme inhibitor quinapril, antagonist of receptors to angiotensin II valsartan, and combination of quinapril and valsartan in patients with moderate chronic heart failure. Main results of the SADK Kardiologiia, 2006, Volume: 46, Issue:7 Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiac Output, Low; Chronic Disease; Drug Therapy, Combination; Exercise Tolerance; Female; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Quinapril; Tetrahydroisoquinolines; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Remodeling	2006
Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure. European journal of heart failure, 2007, Volume: 9, Issue:11 Topics: Aged; Aldosterone; Amides; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Fumarates; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Ramipril; Renin; Statistics, Nonparametric; Treatment Outcome	2007
Vasoconstrictor peptides and cold intolerance in patients with stable angina pectoris. British heart journal, 1995, Volume: 73, Issue:1 Topics: Aged; Angina Pectoris; Angiotensin II; Chronic Disease; Cold Temperature; Electrocardiography; Endothelins; Exercise Test; Humans; Inhalation; Male; Middle Aged; Random Allocation; Time Factors; Vasoconstrictor Agents	1995
[Comparative study on use of angiotensin-converting enzyme inhibitors and cardiac glycosides in the treatment of cardiac insufficiency]. Kardiologiia, 1993, Volume: 33, Issue:12 Topics: Adult; Aged; Angiotensin II; Baroreflex; Captopril; Cardiac Output, Low; Chronic Disease; Digoxin; Double-Blind Method; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Norepinephrine; Sclerosis; Stroke Volume; Time Factors	1993
Angiotensin II and sympathetic activity in patients with congestive heart failure. Journal of the American College of Cardiology, 1993, Volume: 21, Issue:5 Topics: Adult; Aged; Analysis of Variance; Angiotensin II; Blood Pressure; Chronic Disease; Double-Blind Method; Enalaprilat; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Sympathetic Nervous System	1993
Neurohumoral systems in patients with cirrhosis. Renal failure, 1997, Volume: 19, Issue:2 Topics: Adult; Angiotensin II; Chromatography, High Pressure Liquid; Chronic Disease; Dopamine; Hepatitis, Viral, Human; Humans; Liver Cirrhosis, Alcoholic; Liver Function Tests; Male; Middle Aged; Norepinephrine; Prognosis; Renin-Angiotensin System; Severity of Illness Index; Sympathetic Nervous System; Vasopressins	1997
Further evidence that chronic perindopril treatment maintains neurohormonal suppression but does not lower blood pressure in chronic cardiac failure. British journal of clinical pharmacology, 1997, Volume: 44, Issue:1 Topics: Aged; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiac Output, Low; Chronic Disease; Depression, Chemical; Female; Humans; Indoles; Kidney Function Tests; Male; Middle Aged; Perindopril	1997
Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy. Kidney international, 1999, Volume: 56, Issue:2 Topics: Adult; Aged; Angiotensin II; Antihypertensive Agents; Blood Pressure; Chronic Disease; Endothelins; Female; Fibrosis; Follow-Up Studies; Graft Rejection; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Losartan; Male; Middle Aged; Pilot Projects; Proteinuria; Transforming Growth Factor beta; Transplantation, Homologous; Vasoconstrictor Agents	1999
Nonadherence with angiotensin-converting enzyme inhibitor therapy: a comparison of different ways of measuring it in patients with chronic heart failure. Journal of the American College of Cardiology, 1999, Volume: 34, Issue:7 Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Chronic Disease; Diuretics; Drug Therapy, Combination; Echocardiography; Furosemide; Heart Failure; Humans; Lisinopril; Oligopeptides; Peptidyl-Dipeptidase A; Radionuclide Ventriculography; Treatment Outcome; Treatment Refusal	1999
Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation, 2000, Feb-15, Volume: 101, Issue:6 Topics: Aged; Angiotensin I; Angiotensin II; Chronic Disease; Cross-Over Studies; Diuretics; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Forearm; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Spironolactone; Vasodilation	2000
Preliminary experience with the angiotensin II receptor antagonist irbesartan in chronic kidney disease. European journal of pediatrics, 2000, Volume: 159, Issue:8 Topics: Adolescent; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Child; Child, Preschool; Chronic Disease; Female; Humans; Irbesartan; Kidney Diseases; Male; Proteinuria; Renin-Angiotensin System; Tetrazoles; Treatment Outcome	2000
Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro(11)(D)-Ala(12)] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ace production of angiotensin II in humans. Circulation, 2001, Oct-09, Volume: 104, Issue:15 Topics: Administration, Oral; Angina Pectoris; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Captopril; Chronic Disease; Chymases; Dose-Response Relationship, Drug; Double-Blind Method; Hand; Humans; Infusions, Intravenous; Irbesartan; Middle Aged; Peptidyl-Dipeptidase A; Reproducibility of Results; Serine Endopeptidases; Substrate Specificity; Tetrazoles; Vasoconstriction; Veins	2001
Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation, 2001, Oct-23, Volume: 104, Issue:17 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Body Mass Index; Cachexia; Chronic Disease; Energy Metabolism; Female; Ghrelin; Growth Hormone; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Peptide Hormones; Peptides; Predictive Value of Tests; Renin; Tumor Necrosis Factor-alpha	2001
Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure. Journal of the American College of Cardiology, 2002, Mar-06, Volume: 39, Issue:5 Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Vessels; Chronic Disease; Cross-Over Studies; Cross-Sectional Studies; Double-Blind Method; Female; Heart Failure; Humans; Lisinopril; Longitudinal Studies; Male; Middle Aged; Time Factors	2002
Skeletal muscle depressed calcium and phosphofructokinase in chronic heart failure are upregulated by captopril--a double-blind, placebo-controlled study. Journal of internal medicine, 1991, Volume: 229, Issue:2 Topics: Aged; Angiotensin II; Calcium; Captopril; Chronic Disease; Double-Blind Method; Heart Failure; Humans; Middle Aged; Muscles; Phosphofructokinase-1; Serum Albumin	1991

Other Studies

237 other study(ies) available for angiotensin ii and Chronic Disease

Article	Year
Intrarenal renin-angiotensin system activation and macrophage infiltrations in pediatric chronic glomerulonephritis. Pediatric nephrology (Berlin, Germany), 2023, Volume: 38, Issue:11 Topics: Angiotensin II; Angiotensinogen; Chemokine CCL2; Child; Chronic Disease; Glomerulonephritis; Humans; Immunosuppressive Agents; Kidney; Macrophages; Renin-Angiotensin System	2023
ACE (Angiotensin-Converting Enzyme) Inhibition Reverses Vasoconstriction and Impaired Dilation of Pial Collaterals in Chronic Hypertension. Hypertension (Dallas, Tex. : 1979), 2020, Volume: 76, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Captopril; Chronic Disease; Collateral Circulation; Hydralazine; Hypertension; Male; Pia Mater; Random Allocation; Rats; Rats, Inbred SHR; Rats, Wistar; Receptor, Angiotensin, Type 1; rho-Associated Kinases; Tetrazoles; Vasoconstriction; Vasodilator Agents; Vasomotor System	2020
Expression and role of lumican in acute aortic dissection: A human and mouse study. PloS one, 2021, Volume: 16, Issue:7 Topics: Acute Disease; Aminopropionitrile; Angiotensin II; Animals; Aorta; Aortic Dissection; Aortic Rupture; Biomarkers; Chronic Disease; Disease Models, Animal; Humans; Incidence; Kaplan-Meier Estimate; Lumican; Mice; Mice, Inbred C57BL; Mice, Knockout; Smad2 Protein; Transforming Growth Factor beta; Up-Regulation	2021
Research on Q-markers of Qiliqiangxin capsule for chronic heart failure treatment based on pharmacokinetics and pharmacodynamics association. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2018, May-15, Volume: 44 Topics: Aconitine; Angiotensin II; Animals; Benzofurans; Biomarkers; Chromatography, High Pressure Liquid; Chronic Disease; Drugs, Chinese Herbal; Ginsenosides; Heart Failure; Isoflavones; Male; Medicine, Chinese Traditional; Quality Control; Rats, Sprague-Dawley; Tandem Mass Spectrometry	2018
Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity. BMC cardiovascular disorders, 2018, 07-03, Volume: 18, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Chronic Disease; Disease Models, Animal; Endothelial Cells; Heart Diseases; Hypoxia; Male; Mice, Inbred C57BL; Mitochondria, Heart; Myocardium; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Telmisartan	2018
Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension. Circulation research, 2013, May-24, Volume: 112, Issue:11 Topics: 5'-Nucleotidase; Adenosine; Adult; Angiotensin II; Animals; Cells, Cultured; Chronic Disease; Endothelial Cells; Endothelin-1; Female; Gene Expression; GPI-Linked Proteins; Humans; Hypertension, Renal; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Receptor, Adenosine A2B; Signal Transduction; Vasoconstrictor Agents	2013
Angiotensin II-mediated posttranslational modification of nNOS in the PVN of rats with CHF: role for PIN. American journal of physiology. Heart and circulatory physiology, 2013, Sep-15, Volume: 305, Issue:6 Topics: Angiotensin II; Animals; Chronic Disease; Cytoplasmic Dyneins; Heart Failure; Male; Nitric Oxide; Nitric Oxide Synthase Type I; Paraventricular Hypothalamic Nucleus; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Tissue Distribution; Up-Regulation	2013
AVE 0991, a non-peptide mimic of angiotensin-(1-7) effects, attenuates pulmonary remodelling in a model of chronic asthma. British journal of pharmacology, 2013, Volume: 170, Issue:4 Topics: Airway Remodeling; Angiotensin I; Angiotensin II; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Chronic Disease; Cytokines; Disease Models, Animal; Hypertrophy, Right Ventricular; Imidazoles; Lung; Male; Mice; Mice, Inbred BALB C; Molecular Mimicry; Ovalbumin; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Artery; Pulmonary Veins; Receptors, G-Protein-Coupled; Time Factors	2013
Dynamic remodeling of the guinea pig intrinsic cardiac plexus induced by chronic myocardial infarction. Autonomic neuroscience : basic & clinical, 2014, Volume: 181 Topics: Angiotensin II; Animals; Axons; Bethanechol; Chronic Disease; Guinea Pigs; Heart; In Vitro Techniques; Male; Membrane Potentials; Myocardial Infarction; Neurons; Nitric Oxide Synthase Type I; Norepinephrine; Parasympathomimetics; Sympathetic Nervous System; Sympathomimetics; Synaptic Transmission; Time Factors; Vasoconstrictor Agents	2014
Effects of a domain-selective ACE inhibitor in a mouse model of chronic angiotensin II-dependent hypertension. Clinical science (London, England : 1979), 2014, Volume: 127, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Cardiomegaly; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Hypertension; Hypertrophy; Kidney; Lisinopril; Mice; Mice, Transgenic	2014
Intermedin in the paraventricular nucleus attenuates cardiac sympathetic afferent reflex in chronic heart failure rats. PloS one, 2014, Volume: 9, Issue:4 Topics: Adrenomedullin; Afferent Pathways; Angiotensin II; Animals; Blood Pressure; Calcitonin Gene-Related Peptide; Chronic Disease; Heart Failure; Heart Rate; Hemodynamics; Kidney; Male; Neuropeptides; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Rats, Sprague-Dawley; Superoxides; Sympathetic Nervous System	2014
Angiotensin-(1-7) prevents angiotensin II-induced fibrosis in cremaster microvessels. Microcirculation (New York, N.Y. : 1994), 2015, Volume: 22, Issue:1 Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Chronic Disease; Connective Tissue Growth Factor; Dual Specificity Phosphatase 1; Fibrosis; Hypertension; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Muscle, Skeletal; Peptide Fragments; Phosphorylation; Rats; Rats, Inbred Lew; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Vasoconstrictor Agents	2015
Effects of olmesartan therapy on the expression of lung adrenoceptors in rats with chronic heart failure. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2015, Volume: 16, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Proliferation; Chronic Disease; Heart Failure; Imidazoles; Lung; Male; Rats; Rats, Wistar; Receptors, Adrenergic; Renin; RNA, Messenger; Tetrazoles	2015
Effect of angiotensin II on voltage-gated sodium currents in aortic baroreceptor neurons and arterial baroreflex sensitivity in heart failure rats. Journal of hypertension, 2015, Volume: 33, Issue:7 Topics: Angiotensin II; Animals; Aorta; Arteries; Baroreflex; Chronic Disease; Disease Models, Animal; Heart Failure; Losartan; Male; Neurons; Nodose Ganglion; Pressoreceptors; Rats; Rats, Sprague-Dawley; Sodium; Voltage-Gated Sodium Channels	2015
Inhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium Channel. Molecular endocrinology (Baltimore, Md.), 2015, Volume: 29, Issue:6 Topics: Angiotensin II; Animals; Blood Pressure; Calcium; Calcium Channels; Cell Membrane; Chronic Disease; Enzyme Activation; Gene Deletion; HEK293 Cells; Humans; Hypertension; Lysophospholipids; Male; Mice, Inbred C57BL; Phosphotransferases (Alcohol Group Acceptor); Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Sphingosine	2015
Mechanisms of Cachexia in Chronic Disease States. The American journal of the medical sciences, 2015, Volume: 350, Issue:4 Topics: Angiotensin II; Animals; Cachexia; Cell Proliferation; Chronic Disease; Cytokines; Humans; Muscle Proteins; Muscles; Muscular Atrophy; Oxidative Stress; Proteasome Endopeptidase Complex; Proteins; Regeneration; Renin-Angiotensin System; Signal Transduction; Ubiquitin	2015
[Qangxin Granule Intervened Chronic Heart Failure Rats with Xin-qi Deficiency Complicated Blood Stasis and Edema Syndrome: an Experimental Study]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2015, Volume: 35, Issue:5 Topics: Angiotensin II; Animals; C-Reactive Protein; Chronic Disease; Drugs, Chinese Herbal; Edema; Heart; Heart Failure; Heart Ventricles; Medicine, Chinese Traditional; Natriuretic Peptide, Brain; Qi; Rats; Rats, Sprague-Dawley; Syndrome; Thyrotropin; Ventricular Function, Left	2015
Sympathoexcitation in Rats With Chronic Heart Failure Depends on Homeobox D10 and MicroRNA-7b Inhibiting GABBR1 Translation in Paraventricular Nucleus. Circulation. Heart failure, 2016, Volume: 9, Issue:1 Topics: 3' Untranslated Regions; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Binding Sites; Chronic Disease; Disease Models, Animal; Gene Expression Regulation; Heart Failure; HEK293 Cells; Homeodomain Proteins; Humans; Losartan; Male; Mice; MicroRNAs; Oligonucleotides, Antisense; Paraventricular Hypothalamic Nucleus; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, GABA-B; RNA Interference; Sympathetic Nervous System; Transcription Factors; Transfection	2016
Fructus mume Ethanol Extract Prevents Inflammation and Normalizes the Septohippocampal Cholinergic System in a Rat Model of Chronic Cerebral Hypoperfusion. Journal of medicinal food, 2016, Volume: 19, Issue:2 Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Brain Ischemia; Choline O-Acetyltransferase; Cholinergic Agents; Chronic Disease; Cytokines; Disease Models, Animal; Fruit; Hippocampus; Infarction, Middle Cerebral Artery; Inflammation; Male; Mitogen-Activated Protein Kinases; Neuroglia; Plant Extracts; Prunus; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products	2016
THE RENIN-ANGIOTENSIN SYSTEM AND THE BIOLOGY OF SKELETAL MUSCLE: MECHANISMS OF MUSCLE WASTING IN CHRONIC DISEASE STATES. Transactions of the American Clinical and Climatological Association, 2016, Volume: 127 Topics: Angiotensin II; Animals; Cachexia; Chronic Disease; Humans; Mice; Muscle, Skeletal; Muscular Atrophy; Renin-Angiotensin System; Sarcopenia	2016
Role of oxidant stress on AT1 receptor expression in neurons of rabbits with heart failure and in cultured neurons. Circulation research, 2008, Jul-18, Volume: 103, Issue:2 Topics: Angiotensin II; Animals; Antioxidants; Cells, Cultured; Chronic Disease; Cyclic N-Oxides; Disease Models, Animal; Heart Failure; Male; MAP Kinase Kinase 4; NADPH Oxidases; Neurons; Oxidative Stress; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rabbits; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; RNA, Messenger; Spin Labels; Superoxides; Transcription Factor AP-1	2008
Angiotensin II-triggered p44/42 mitogen-activated protein kinase mediates sympathetic excitation in heart failure rats. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:2 Topics: Acute Disease; Analysis of Variance; Angiotensin II; Animals; Chronic Disease; Disease Models, Animal; Flavonoids; Fluorescent Antibody Technique; Heart Failure; Hemodynamics; Immunohistochemistry; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Sympathetic Nervous System	2008
Exercise training improves peripheral chemoreflex function in heart failure rabbits. Journal of applied physiology (Bethesda, Md. : 1985), 2008, Volume: 105, Issue:3 Topics: Action Potentials; Angiotensin II; Animals; Cardiac Pacing, Artificial; Carotid Body; Chronic Disease; Citrulline; Disease Models, Animal; Enzyme Inhibitors; Exercise Therapy; Heart Failure; Hemodynamics; Hypoxia; Kidney; Male; Nitric Oxide; Nitric Oxide Synthase Type I; Physical Exertion; Rabbits; Receptor, Angiotensin, Type 1; Reflex; Signal Transduction; Sympathetic Nervous System; Thiourea	2008
The best medicine: exercise training normalizes chemosensitivity and sympathoexcitation in heart failure. Journal of applied physiology (Bethesda, Md. : 1985), 2008, Volume: 105, Issue:3 Topics: Action Potentials; Angiotensin II; Animals; Carotid Body; Chronic Disease; Exercise Therapy; Heart Failure; Hemodynamics; Humans; Kidney; Nitric Oxide; Nitric Oxide Synthase Type I; Physical Exertion; Receptor, Angiotensin, Type 1; Reflex; Signal Transduction; Sympathetic Nervous System	2008
Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female rats. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Heart Ventricles; Hypertension; Kidney; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; RNA, Messenger; Vasodilation	2008
Role of the median preoptic nucleus in chronic angiotensin II-induced hypertension. Brain research, 2008, Oct-31, Volume: 1238 Topics: Angiotensin II; Animals; Cardiovascular System; Chronic Disease; Excitatory Amino Acid Agonists; Hypertension; Ibotenic Acid; Injections, Intraventricular; Male; Neurons; Preoptic Area; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents	2008
Angiotensin II vaccine promising for patients with chronic heart failure. Chinese medical journal, 2009, Jan-05, Volume: 122, Issue:1 Topics: Angiotensin II; Chronic Disease; Heart Failure; Humans; Renin-Angiotensin System; Vaccines	2009
Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II system-mediated chronic inflammation. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chemokine CCL2; Chronic Disease; Disease Models, Animal; Heart Diseases; Heart Ventricles; Hypertension; Hypertrophy; Inflammation; Macrophages; Male; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Transforming Growth Factor beta; Ventricular Remodeling	2009
Spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2010, Volume: 30, Issue:1 Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Fluorescent Antibody Technique; Gelatin; Hypertension; Immunohistochemistry; Intracranial Hemorrhages; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Norepinephrine; Oxidative Stress; Reverse Transcriptase Polymerase Chain Reaction; Stroke; Vasoconstrictor Agents	2010
Long-term blockade of L/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart. British journal of pharmacology, 2009, Volume: 158, Issue:5 Topics: Action Potentials; Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atrioventricular Block; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Cardiomegaly; Chronic Disease; Dihydropyridines; Dogs; Electrocardiography; Epinephrine; Female; Male; Neurotransmitter Agents; Norepinephrine; Tetrazoles; Time Factors	2009
Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis. American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Apoptosis; Blood Pressure; Cell Proliferation; Cells, Cultured; Chronic Disease; Collagen; Disease Models, Animal; Fibrinolysin; Fibrosis; Glomerular Filtration Rate; Imidazoles; Kidney; Kidney Diseases; Losartan; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nephrectomy; Phosphorylation; Plasminogen Activator Inhibitor 1; Podocytes; Proteinuria; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; RNA, Messenger; Time Factors	2010
Downregulated Kv4.3 expression in the RVLM as a potential mechanism for sympathoexcitation in rats with chronic heart failure. American journal of physiology. Heart and circulatory physiology, 2010, Volume: 298, Issue:3 Topics: Angiotensin II; Animals; Body Weight; Chronic Disease; Disease Models, Animal; Down-Regulation; Heart Failure; Hemodynamics; Male; Medulla Oblongata; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Shal Potassium Channels; Signal Transduction; Sympathetic Nervous System	2010
Chronic angiotensin II infusion causes differential responses in regional sympathetic nerve activity in rats. Hypertension (Dallas, Tex. : 1979), 2010, Volume: 55, Issue:3 Topics: Angiotensin II; Animals; Blood Pressure; Cardiovascular System; Chronic Disease; Heart Rate; Hindlimb; Hypertension; Kidney; Lumbosacral Region; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Sympathetic Nervous System; Vasoconstrictor Agents	2010
Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:6 Topics: Albuminuria; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Chronic Disease; Disease Models, Animal; Glomerular Filtration Rate; Hematocrit; Imidazoles; Infusion Pumps; Injections, Subcutaneous; Inulin; Kidney; Kidney Diseases; Leucine; Losartan; Male; Mice; Nephrectomy; Organ Size; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Time Factors	2010
Simultaneous administration of Ang(1-7) or A-779 does not affect the chronic hypertensive effects of angiotensin II in normal rats. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2010, Volume: 11, Issue:2 Topics: Angiotensin II; Animals; Blood Pressure; Chronic Disease; Drug Therapy, Combination; Heart Rate; Hypertension; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley	2010
Involvement of angiotensin II in the remodeling induced by a chronic decrease in blood flow in rat mesenteric resistance arteries. Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:8 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Chronic Disease; Extracellular Signal-Regulated MAP Kinases; Hypertension; Mesenteric Arteries; Mice; Mice, Knockout; Nitric Oxide Synthase Type III; Perindopril; Rats; Rats, Wistar; Reactive Oxygen Species; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents	2010
Angiotensin II sustains brain inflammation in mice via TGF-beta. The Journal of clinical investigation, 2010, Volume: 120, Issue:8 Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Chronic Disease; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Tetrazoles; Thrombospondin 1; Transforming Growth Factor beta	2010
Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney international, 2010, Volume: 78, Issue:11 Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chronic Disease; Desoxycorticosterone; Disease Models, Animal; Disease Progression; Fibrosis; Genetic Predisposition to Disease; Glomerulonephritis; Heart Diseases; Hydralazine; Hypertension; Imidazoles; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney; Kidney Diseases; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Nephrectomy; Sodium Chloride, Dietary; Species Specificity; Telemetry; Tetrazoles; Time Factors; X-Ray Microtomography	2010
Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:3 Topics: 8-Hydroxy-2'-Deoxyguanosine; Aging; Angiotensin II; Animals; Blotting, Western; Chronic Disease; Cyclosporine; Deoxyguanosine; Disease Models, Animal; Glucuronidase; Immunoenzyme Techniques; Immunosuppressive Agents; Kidney Diseases; Klotho Proteins; Male; Mice; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation; Vasoconstrictor Agents	2011
Regional myocardial function and response to acute afterload increase in chronically anemic fetal sheep: evaluation by two-dimensional strain echocardiography. Ultrasound in medicine & biology, 2010, Volume: 36, Issue:12 Topics: Anemia; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Echocardiography; Female; Fetal Diseases; Myocardial Contraction; Pregnancy; Sheep, Domestic; Stroke Volume; Ultrasonography, Prenatal; Vasoconstrictor Agents; Ventricular Function, Left; Ventricular Remodeling	2010
A2B adenosine receptor-mediated induction of IL-6 promotes CKD. Journal of the American Society of Nephrology : JASN, 2011, Volume: 22, Issue:5 Topics: Adenosine Deaminase; Angiotensin II; Animals; Chronic Disease; Collagen; Fibrosis; Humans; Interleukin-6; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Adenosine A2B; Signal Transduction; Ureteral Obstruction	2011
Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation. American journal of physiology. Renal physiology, 2011, Volume: 301, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Blood Pressure; Chronic Disease; Disease Models, Animal; Diuretics; Drug Therapy, Combination; Female; Hydrochlorothiazide; Kidney; Kidney Diseases; Lactation; Losartan; Male; Nephrons; Rats; Rats, Inbred Strains	2011
Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: role for CAPON and Ang II. Cardiovascular research, 2011, Nov-01, Volume: 92, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Line, Tumor; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Heart Failure; Hemodynamics; Immunohistochemistry; Kidney; Losartan; Male; Microinjections; Nitric Oxide Synthase Type I; omega-N-Methylarginine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, N-Methyl-D-Aspartate; RNA Interference; RNA, Messenger; Sympathetic Nervous System; Time Factors	2011
Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failure. Hypertension (Dallas, Tex. : 1979), 2011, Volume: 58, Issue:4 Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Baroreflex; Chronic Disease; Consciousness; Disease Models, Animal; Heart Failure; Heart Rate; Infusions, Intraventricular; Kidney; Male; Metoprolol; Peptide Fragments; Rabbits; Sympathetic Nervous System; Vagus Nerve	2011
Silencing of hypoxia-inducible factor-1α gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats. Hypertension (Dallas, Tex. : 1979), 2011, Volume: 58, Issue:4 Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Creatinine; Disease Models, Animal; Gene Expression Regulation; Gene Silencing; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Diseases; Kidney Glomerulus; Male; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Vascular Endothelial Growth Factor A	2011
Inhibition of cardiac sympathetic afferent reflex and sympathetic activity by baroreceptor and vagal afferent inputs in chronic heart failure. PloS one, 2011, Volume: 6, Issue:10 Topics: Angiotensin II; Animals; Blood Pressure; Capsaicin; Chronic Disease; Heart; Heart Failure; Heart Rate; Kidney; Male; Microinjections; Neurons, Afferent; Paraventricular Hypothalamic Nucleus; Pressoreceptors; Rats; Rats, Sprague-Dawley; Reflex; Sodium Chloride; Sympathetic Nervous System; Vagus Nerve	2011
High dietary salt and angiotensin II chronically increase renal sympathetic nerve activity: a direct telemetric study. Hypertension (Dallas, Tex. : 1979), 2012, Volume: 59, Issue:3 Topics: Action Potentials; Angiotensin II; Animals; Baroreflex; Blood Pressure; Chronic Disease; Disease Models, Animal; Female; Follow-Up Studies; Hypertension; Kidney; Male; Rabbits; Sodium Chloride, Dietary; Sympathetic Nervous System; Telemetry	2012
Parallel changes in neuronal AT1R and GRK5 expression following exercise training in heart failure. Hypertension (Dallas, Tex. : 1979), 2012, Volume: 60, Issue:2 Topics: Angiotensin II; Animals; Cells, Cultured; Chronic Disease; Disease Models, Animal; G-Protein-Coupled Receptor Kinase 5; Heart Failure; Male; Medulla Oblongata; Neurons; NF-kappa B; Paraventricular Hypothalamic Nucleus; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Up-Regulation	2012
MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway. Circulation, 2012, Aug-14, Volume: 126, Issue:7 Topics: Angiotensin II; Animals; Animals, Newborn; Cell Proliferation; Cells, Cultured; Chronic Disease; Collagen; Compliance; Echocardiography; Fibroblasts; Fibrosis; Gene Silencing; Hemodynamics; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Myocardial Infarction; Myocardium; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Treatment Outcome; Vasoconstrictor Agents; Ventricular Dysfunction, Left	2012
Remodeling of intrinsic cardiac neurons: effects of β-adrenergic receptor blockade in guinea pig models of chronic heart disease. American journal of physiology. Regulatory, integrative and comparative physiology, 2012, Nov-01, Volume: 303, Issue:9 Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Cholinergic Agents; Chronic Disease; Disease Models, Animal; Evoked Potentials; Guinea Pigs; Heart; Heart Diseases; Male; Myocardial Infarction; Neurons; Receptors, Adrenergic, beta; Timolol	2012
ER stress in the brain subfornical organ mediates angiotensin-dependent hypertension. The Journal of clinical investigation, 2012, Volume: 122, Issue:11 Topics: Angiotensin II; Animals; Brain; Cholagogues and Choleretics; Chronic Disease; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Heat-Shock Proteins; Hypertension; Mice; Subfornical Organ; Taurochenodeoxycholic Acid; Vasoconstrictor Agents	2012
Upregulation of autocrine-paracrine renin-angiotensin systems in chronic renovascular hypertension. Journal of vascular surgery, 2002, Volume: 36, Issue:2 Topics: Adrenal Glands; Angiotensin II; Animals; Autocrine Communication; Chronic Disease; Disease Models, Animal; Hypertension, Renovascular; Immunohistochemistry; Kidney; Kidney Tubules, Proximal; Radioimmunoassay; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin-Angiotensin System; Up-Regulation	2002
Effect of load alterations on the effective regurgitant orifice area in chronic aortic regurgitation. Heart (British Cardiac Society), 2002, Volume: 88, Issue:4 Topics: Angiotensin II; Animals; Aortic Valve Insufficiency; Blood Flow Velocity; Blood Transfusion; Chronic Disease; Echocardiography, Doppler; Hemodynamics; Nitroprusside; Regression Analysis; Sheep; Vasoconstrictor Agents; Vasodilator Agents	2002
Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy. Transplantation, 2003, Feb-15, Volume: 75, Issue:3 Topics: Angiotensin II; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Body Weight; Chronic Disease; Cyclosporine; Drug Synergism; Fibrosis; Gene Expression; Immunosuppressive Agents; Kidney; Kidney Diseases; Losartan; Macrophages; Male; Mycophenolic Acid; Osteopontin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Transforming Growth Factor beta; Transforming Growth Factor beta1	2003
Decreased facilitation by angiotensin II of noradrenergic neurotransmission in isolated mesenteric artery of rabbits with chronic heart failure. Journal of cardiovascular pharmacology, 2003, Volume: 41, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Chronic Disease; Electric Stimulation; Heart Failure; In Vitro Techniques; Male; Mesenteric Arteries; Neural Inhibition; Norepinephrine; Rabbits; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Synaptic Transmission; Vasoconstriction	2003
Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load. Kidney international, 2003, Volume: 63, Issue:4 Topics: Adult; Aldosterone; Angiotensin II; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Atrial Natriuretic Factor; Chronic Disease; Drinking; Female; Heart Failure; Humans; Liver Cirrhosis; Male; Middle Aged; Natriuretic Peptide, Brain; Osmolar Concentration; Renin; Urine; Water-Electrolyte Balance	2003
Improved neurohormonal markers of ventricular function after restoring sinus rhythm by the Maze procedure. The Annals of thoracic surgery, 2003, Volume: 75, Issue:3 Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Fibrillation; Atrial Natriuretic Factor; Chronic Disease; Cryosurgery; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Postoperative Complications; Vasopressins; Ventricular Dysfunction, Left; Ventricular Function, Left	2003
Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade. British journal of pharmacology, 2003, Volume: 139, Issue:7 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Captopril; Chronic Disease; Coronary Vessels; Disease Models, Animal; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Fatty Acids, Unsaturated; Heart; Heart Failure; Hydrazines; Imidazoles; Indomethacin; Lisinopril; Losartan; Male; Mesenteric Arteries; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Superoxide Dismutase; Sympathetic Nervous System; Tetrazoles; Tetrodotoxin; Vascular Resistance	2003
The role of Ang (1-7) in mediating the chronic hypotensive effects of losartan in normal rats. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2003, Volume: 4, Issue:3 Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Chronic Disease; Drug Interactions; Heart Rate; Hypotension; Losartan; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley	2003
The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: frustration and promises. Kidney international, 2003, Volume: 64, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Clinical Trials as Topic; Disease Progression; Glomerular Filtration Rate; Humans; Hypertension, Renal; Kidney Diseases; Kidney Glomerulus; Proteinuria	2003
Changes of central norepinephrine, beta-endorphin, LEU-enkephalin, peripheral arginine-vasopressin, and angiotensin II levels in acute and chronic phases of sino-aortic denervation in rats. Journal of cardiovascular pharmacology, 2004, Volume: 43, Issue:2 Topics: Angiotensin II; Animals; Arginine Vasopressin; Baroreflex; beta-Endorphin; Blood Pressure; Brain; Chronic Disease; Denervation; Enkephalin, Leucine; Heart Rate; Hypertension; Male; Norepinephrine; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Sinoatrial Node	2004
Remodeling of the chronic severely failing ischemic sheep heart after coronary microembolization: functional, energetic, structural, and cellular responses. American journal of physiology. Heart and circulatory physiology, 2004, Volume: 286, Issue:6 Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Caspase 2; Caspase 3; Caspase 8; Caspases; Chronic Disease; Collagen; Coronary Vessels; Embolism; Extracellular Matrix; Fas Ligand Protein; Female; Heart Failure; Male; Membrane Glycoproteins; Microcirculation; Microspheres; Myocardial Contraction; Myocardial Ischemia; Myocardium; Severity of Illness Index; Sheep; Stroke Volume; Ventricular Remodeling	2004
Sildenafil alters calcium signaling and vascular tone in pulmonary arteries from chronically hypoxic rats. American journal of physiology. Lung cellular and molecular physiology, 2004, Volume: 287, Issue:3 Topics: Angiotensin II; Animals; Caffeine; Calcium; Calcium Signaling; Chronic Disease; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Male; Muscle, Smooth, Vascular; Phenylephrine; Phosphodiesterase Inhibitors; Piperazines; Pulmonary Artery; Purines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones; Vasoconstriction; Vasoconstrictor Agents	2004
ANG II in the paraventricular nucleus potentiates the cardiac sympathetic afferent reflex in rats with heart failure. Journal of applied physiology (Bethesda, Md. : 1985), 2004, Volume: 97, Issue:5 Topics: Angiotensin II; Animals; Arteries; Cardiac Output, Low; Chronic Disease; Coronary Vessels; Dose-Response Relationship, Drug; Electric Stimulation; Heart; Hemodynamics; Kidney; Ligation; Losartan; Male; Microinjections; Neurons, Afferent; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Reflex; Sympathetic Nervous System; Vasoconstrictor Agents	2004
Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 313, Issue:1 Topics: Actins; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Body Weight; Chronic Disease; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Fibrosis; Genes, ras; Hydroxyproline; Immunohistochemistry; Lisinopril; Male; Organ Size; Pancreatitis; Peptidyl-Dipeptidase A; Peroxidase; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles	2005
Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat. Circulation, 2005, Jan-04, Volume: 111, Issue:1 Topics: Aldosterone; Angiotensin II; Animals; Atrial Fibrillation; Atrial Natriuretic Factor; Cardiac Pacing, Artificial; Cardiomegaly; Cell Size; Chronic Disease; Connexin 43; Connexins; Female; Gap Junction alpha-5 Protein; Goats; Heart Block; Heart Conduction System; Hemodynamics; Hypertrophy; Myocytes, Cardiac; Neural Conduction; Norepinephrine; Refractory Period, Electrophysiological	2005
Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase. Hypertension (Dallas, Tex. : 1979), 2005, Volume: 45, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Chronic Disease; Collagen; Humans; Hypertension; Kidney; Membrane Glycoproteins; Mice; Mice, Transgenic; Myocardium; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Reactive Oxygen Species; Renin; Tyrosine	2005
Effects of alpha-lipoic acid on kinin B1 and B2 receptor binding sites in the spinal cord of chronically angiotensin-treated rats. Peptides, 2005, Volume: 26, Issue:8 Topics: Angiotensin II; Animals; Binding Sites; Blood Glucose; Blood Pressure; Body Weight; Chronic Disease; Diet; Disease Models, Animal; Insulin; Rats; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Spinal Cord; Superoxides; Thioctic Acid	2005
Effect of FTY720 on chronic cyclosporine nephropathy in rats. Transplantation, 2005, Nov-15, Volume: 80, Issue:9 Topics: Angiotensin II; Animals; Chronic Disease; Cyclosporine; Extracellular Matrix Proteins; Fibrosis; Fingolimod Hydrochloride; Immunosuppressive Agents; Kidney; Kidney Diseases; Lymphocytes; Macrophages; Male; Osteopontin; Propylene Glycols; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Sphingosine; T-Lymphocytes; Transforming Growth Factor beta; Transforming Growth Factor beta1	2005
Apolipoprotein E and progression of chronic kidney disease. JAMA, 2006, Jan-04, Volume: 295, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Apolipoproteins E; Chronic Disease; Disease Progression; Humans; Kidney Diseases; Risk Factors	2006
Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension. Vascular pharmacology, 2007, Volume: 46, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Bradykinin; Chronic Disease; Cyclic N-Oxides; Dinoprost; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enalapril; Hydrogen Peroxide; Hypertension; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Bradykinin; Spin Labels; Superoxides; Time Factors	2007
Early left ventricular gene expression profile in response to increase in blood pressure. Blood pressure, 2006, Volume: 15, Issue:6 Topics: Acute Disease; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arginine Vasopressin; bcl-X Protein; Blood Pressure; Cell Cycle Proteins; Chronic Disease; Consciousness; DNA, Complementary; Early Growth Response Protein 1; Eye Proteins; Fatty Acid-Binding Proteins; Gene Expression Profiling; Gene Expression Regulation; Heart Ventricles; HSP70 Heat-Shock Proteins; Hypertension; Losartan; Male; Nerve Growth Factor; Nerve Tissue Proteins; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger	2006
Exercise training in chronic heart failure: how to harmonize oxidative stress, sympathetic outflow, and angiotensin II. Circulation, 2007, Jun-19, Volume: 115, Issue:24 Topics: Angiotensin II; Chronic Disease; Exercise; Exercise Therapy; Heart Failure; Humans; Oxidative Stress; Sympathetic Nervous System	2007
Renal inflammation is modulated by potassium in chronic kidney disease: possible role of Smad7. American journal of physiology. Renal physiology, 2007, Volume: 293, Issue:4 Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Creatinine; Disease Models, Animal; Kidney; Kidney Diseases; Male; Nephritis; NF-kappa B; Potassium; Potassium, Dietary; Rats; Rats, Sprague-Dawley; Smad7 Protein; Sodium; Transforming Growth Factor beta	2007
Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure. Hypertension (Dallas, Tex. : 1979), 2007, Volume: 50, Issue:5 Topics: Angiotensin II; Animals; Blood Pressure; Cardiac Pacing, Artificial; Carotid Sinus; Chronic Disease; Dogs; Echocardiography; Electric Stimulation Therapy; Electrocardiography; Electrodes, Implanted; Heart Failure; Heart Rate; Male; Norepinephrine; Pressoreceptors; Stroke Volume; Survival Analysis	2007
Exercise training enhances baroreflex sensitivity by an angiotensin II-dependent mechanism in chronic heart failure. Journal of applied physiology (Bethesda, Md. : 1985), 2008, Volume: 104, Issue:3 Topics: Angiotensin II; Animals; Baroreflex; Chronic Disease; Disease Models, Animal; Down-Regulation; Exercise Therapy; Heart Failure; Hemodynamics; Infusion Pumps, Implantable; Kidney; Male; Medulla Oblongata; Nitroprusside; Phenylephrine; Physical Conditioning, Animal; Rabbits; Receptor, Angiotensin, Type 1; RNA, Messenger; Sympathetic Nervous System; Time Factors; Vasoconstrictor Agents; Vasodilator Agents	2008
Exercise training in heart failure: reduction in angiotensin II, sympathetic nerve activity, and baroreflex control. Journal of applied physiology (Bethesda, Md. : 1985), 2008, Volume: 104, Issue:3 Topics: Angiotensin II; Animals; Baroreflex; Chronic Disease; Disease Models, Animal; Down-Regulation; Exercise Therapy; Heart Failure; Hemodynamics; Humans; Kidney; Medulla Oblongata; Receptor, Angiotensin, Type 1; RNA, Messenger; Sympathetic Nervous System	2008
Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:2 Topics: Angiotensin II; Animals; Blood Pressure; Chronic Disease; CSK Tyrosine-Protein Kinase; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; Hypertension; Kidney; Male; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Oxidation-Reduction; Oxidative Stress; Phosphorylation; Procollagen; Protein Isoforms; Protein-Tyrosine Kinases; Renin; Signal Transduction; src-Family Kinases; Systole; Vascular Cell Adhesion Molecule-1	2008
Pioglitazone opposes neurogenic vascular dysfunction associated with chronic hyperinsulinaemia. British journal of pharmacology, 2008, Volume: 153, Issue:7 Topics: Administration, Oral; Angiotensin II; Animals; Blood Glucose; Blood Pressure; Chronic Disease; Disease Models, Animal; Hyperinsulinism; Hypertension; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Norepinephrine; Pioglitazone; Random Allocation; Rats; Rats, Wistar; Thiazolidinediones; Triglycerides; Vasoconstriction	2008
Whole body norepinephrine kinetics in ANG II-salt hypertension in the rat. American journal of physiology. Regulatory, integrative and comparative physiology, 2008, Volume: 294, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Chronic Disease; Disease Models, Animal; Heart Rate; Hypertension; Infusion Pumps, Implantable; Kinetics; Male; Norepinephrine; Radioisotope Dilution Technique; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Sympathetic Nervous System; Tritium	2008
Chronic hypoxia increases fetoplacental vascular resistance and vasoconstrictor reactivity in the rat. American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:4 Topics: Angiotensin II; Animals; Blood Flow Velocity; Blood Pressure; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Gestational Age; Hypoxia; Nitroprusside; Placental Circulation; Pregnancy; Rats; Rats, Wistar; Regional Blood Flow; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents	2008
The plasma angiotensin II level increases in very low-birth weight infants with neonatal chronic lung disease. Early human development, 2008, Volume: 84, Issue:6 Topics: Angiotensin II; Birth Weight; Chronic Disease; Female; Gestational Age; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Lung Diseases; Male; Renin-Angiotensin System; Respiration, Artificial	2008
Aldosterone responses to angiotensin II, adrenocorticotropin, and potassium in chronic experimental diabetes mellitus in rats. Endocrinology, 1984, Volume: 115, Issue:6 Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Chronic Disease; Diabetes Mellitus, Experimental; Insulin; Male; Potassium; Potassium Chloride; Rats; Rats, Inbred Strains; Renin; Streptozocin	1984
Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1983, Volume: 1, Issue:1 Topics: Aged; Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Electrolytes; Enalapril; Female; Furosemide; Heart Failure; Heart Rate; Hemodynamics; Humans; Kinetics; Male; Middle Aged; Renin; Vascular Resistance	1983
Effect of angiotensin II antagonist, alpha-receptor blockage, and denervation on blood flow reduction in experimental, chronic hydronephrosis. Investigative urology, 1980, Volume: 18, Issue:3 Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Adrenergic alpha-Antagonists; Angiotensin II; Animals; Chronic Disease; Denervation; Dogs; Female; Hydronephrosis; Kidney; Male; Naphthalenes; Phenethylamines; Regional Blood Flow; Tetrahydronaphthalenes; Tetralones	1980
Pathophysiology of pregnancy-induced hypertension. Clinical obstetrics and gynecology, 1984, Volume: 27, Issue:4 Topics: Angiotensin II; Biological Transport; Calcium; Chronic Disease; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desoxycorticosterone; Disseminated Intravascular Coagulation; Eclampsia; Estradiol; Female; HLA Antigens; Humans; Placenta; Pre-Eclampsia; Pregnancy; Prostaglandins; Thrombocytopenia; Vasoconstriction; Vasomotor System	1984
Acute and chronic systemic and pulmonary hemodynamic effects of angiotensin converting enzyme inhibition with captopril in hypertensive patients. The American journal of cardiology, 1980, Volume: 46, Issue:2 Topics: Acute Disease; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output; Chronic Disease; Female; Heart Rate; Hemodynamics; Humans; Hypertension, Renal; Hypertension, Renovascular; Long-Term Care; Lung; Male; Middle Aged; Proline; Stroke Volume; Vascular Resistance	1980
Estimation of angiotensin II receptor activity in chronic congestive heart failure. American heart journal, 1984, Volume: 108, Issue:1 Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Hypotension, Orthostatic; Male; Middle Aged; Receptors, Angiotensin; Receptors, Cell Surface; Renin; Saralasin; Sodium	1984
Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure. Cardiology, 1983, Volume: 70, Issue:6 Topics: Adult; Aged; Angiotensin II; Captopril; Chronic Disease; Coronary Disease; Dinoprostone; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Proline; Prostaglandins E; Renin; Renin-Angiotensin System	1983
Plasma catecholamines and cardiovascular response in mild renal failure. Contributions to nephrology, 1984, Volume: 41 Topics: Adult; Aged; Aldosterone; Angiotensin II; Catecholamines; Chronic Disease; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney Diseases; Male; Middle Aged; Renal Circulation; Renin; Sodium	1984
Echocardiographic evaluation of the response to afterload stress test in young asymptomatic patients with chronic severe aortic regurgitation: sensitivity of the left ventricular end-systolic pressure-volume relationship. Circulation, 1984, Volume: 70, Issue:4 Topics: Adolescent; Adult; Angiotensin II; Aortic Valve Insufficiency; Blood Pressure; Cardiac Output; Chronic Disease; Echocardiography; Exercise Test; Female; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Stroke Volume; Systole	1984
The role of vascular hypertrophy in early and chronic renovascular hypertension. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1983, Volume: 1, Issue:2 Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Female; Hypertension, Renovascular; Hypertrophy; Norepinephrine; Perfusion; Rats; Rats, Inbred Strains; Renal Artery	1983
Different antagonist potency of saralasin in acute and chronic angiotensin-dependent hypertension. European journal of pharmacology, 1983, Sep-02, Volume: 92, Issue:3-4 Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Chronic Disease; Hypertension, Malignant; Hypertension, Renovascular; Male; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Saralasin	1983
Sodium status and the renin-angiotensin-aldosterone system in compensated liver disease. European journal of clinical investigation, 1981, Volume: 11, Issue:4 Topics: Adult; Aldosterone; Analysis of Variance; Angiotensin II; Chronic Disease; Female; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Renin; Sodium	1981
Response of chronic renovascular hypertension to surgical correction or prolonged blockade of the renin-angiotensin system by two inhibitors in the rat. Clinical science (London, England : 1979), 1980, Volume: 58, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Chronic Disease; Female; Hypertension, Renal; Hypertension, Renovascular; Nephrectomy; Proline; Rats; Renin; Saralasin	1980
[Renal hemodynamics, the renin-angiotensin system and prostaglandins in the malignant and stable course of arterial hypertension]. Kardiologiia, 1980, Volume: 20, Issue:4 Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Chronic Disease; Female; Hemodynamics; Humans; Hypertension, Malignant; Hypertension, Renal; Hypertension, Renovascular; Kidney; Male; Middle Aged; Oxygen; Prostaglandins; Renin	1980
Effect of the angiotensin antagonist saralasin on hemodynamics in hypertensive non-uraemic chronic renal disease. Nephron, 1980, Volume: 25, Issue:4 Topics: Adult; Angiotensin II; Blood Pressure; Chronic Disease; Female; Forearm; Heart Rate; Humans; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Regional Blood Flow; Renin; Saralasin; Vascular Resistance	1980
Atherosclerosis in uremia: a longitudinal study. The American journal of clinical nutrition, 1980, Volume: 33, Issue:7 Topics: Angiotensin II; Arteriosclerosis; Blood Pressure; Cholesterol; Chronic Disease; Humans; Hyperlipidemias; Kidney Transplantation; Lipoproteins; Renal Dialysis; Transplantation, Homologous; Triglycerides; Uremia	1980
Decreased sensitivity to angiotensin II in chronic sustained hypernatremia. Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association, 1980, Volume: 79, Issue:4 Topics: Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Humans; Hypernatremia; Male; Middle Aged; Renin; Vasopressins	1980
The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril). Japanese circulation journal, 1980, Volume: 44, Issue:6 Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Captopril; Catecholamines; Chronic Disease; Heart Failure; Heart Rate; Humans; Middle Aged; Norepinephrine; Proline; Renin; Sympathetic Nervous System; Time Factors; Vascular Resistance	1980
[Renal alterations in chronic respiratory insufficiency physiopathologic considerations (author's transl)]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1981, Jun-30, Volume: 70, Issue:27 Topics: Acidosis; Aldosterone; Angiotensin II; Chronic Disease; Humans; Hypercapnia; Hypoxia; Mineralocorticoid Receptor Antagonists; Renal Circulation; Renin; Respiratory Insufficiency; Sodium	1981
Vascular responsiveness and body fluid status in patients on chronic hemodialysis. Journal of dialysis, 1980, Volume: 4, Issue:4 Topics: Adult; Angiotensin II; Blood Circulation; Blood Pressure; Body Fluids; Body Weight; Chronic Disease; Humans; Hypotension; Middle Aged; Norepinephrine; Renal Dialysis	1980
[Cerebral vascular reactivity of cats with chronic hypertension]. Patologicheskaia fiziologiia i eksperimental'naia terapiia, 1981, Issue:6 Topics: Angiotensin II; Animals; Blood Pressure; Brain; Cats; Cerebral Arteries; Chronic Disease; Hemodynamics; Hypertension; Norepinephrine; Vascular Resistance; Veins	1981
Depression of heart function after angiotensin II infusion in patients on chronic hemodialysis. Clinical and experimental dialysis and apheresis, 1981, Volume: 5, Issue:4 Topics: Adult; Angiotensin II; Blood Pressure; Chronic Disease; Female; Glomerulonephritis; Heart; Humans; Hypertension; Male; Middle Aged; Nephrotic Syndrome; Renal Dialysis; Tuberculosis, Renal	1981
Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. American heart journal, 1995, Volume: 129, Issue:5 Topics: Analysis of Variance; Angiotensin II; Animals; Chronic Disease; Disease Models, Animal; Fibroblast Growth Factor 2; Hypertrophy, Left Ventricular; Infusion Pumps, Implantable; Male; Myocardial Ischemia; Neovascularization, Pathologic; Pericardium; Rabbits; Statistics, Nonparametric; Stimulation, Chemical	1995
Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function. Thorax, 1994, Volume: 49, Issue:5 Topics: Acute Disease; Adult; Angiotensin II; Asthma; Blood Pressure; Bronchoconstriction; Chronic Disease; Female; Forced Expiratory Volume; Humans; Male; Oxygen; Renin; Renin-Angiotensin System; Sodium	1994
[The effect of the one-time and long-term administration of preparations acting on biogenic amine metabolism on the blood level of pressor peptide hormones]. Likars'ka sprava, 1993, Issue:9 Topics: Adolescent; Adult; Angiotensin II; Biogenic Amines; Blood Pressure; Bromocriptine; Chronic Disease; Cyproheptadine; Drug Evaluation; Female; Humans; Hypertension; Hypothalamic Diseases; Male; Middle Aged; Syndrome; Time Factors; Vasopressins	1993
Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure. American heart journal, 1994, Volume: 127, Issue:3 Topics: Adult; Aged; Angiotensin II; Blood Coagulation; Blood Viscosity; Chronic Disease; Endothelins; Exercise Test; Female; Fibrin Fibrinogen Degradation Products; Fibrinopeptide A; Heart Failure; Humans; Male; Middle Aged; Neurosecretory Systems; Platelet Activation; Radionuclide Ventriculography; Thromboembolism; von Willebrand Factor	1994
Altered pressure natriuresis in chronic angiotensin II hypertension in rats. The American journal of physiology, 1994, Volume: 266, Issue:3 Pt 2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Chronic Disease; Hypertension; Imidazoles; Losartan; Male; Natriuresis; Rats; Rats, Sprague-Dawley; Reference Values; Tetrazoles	1994
Platelet angiotensin II binding in pregnant women with chronic hypertension. American journal of obstetrics and gynecology, 1994, Volume: 170, Issue:5 Pt 1 Topics: Adolescent; Adult; Angiotensin II; Chronic Disease; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Third	1994
[Effect of cilazapril on exercise tolerance and neurohumoral factors in patients with asymptomatic chronic heart failure after myocardial infarction]. Journal of cardiology, 1995, Volume: 26, Issue:5 Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Chronic Disease; Cilazapril; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Neurotransmitter Agents; Norepinephrine; Renin; Stroke Volume	1995
Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. The American journal of physiology, 1995, Volume: 269, Issue:6 Pt 2 Topics: Angiotensin II; Animals; Chronic Disease; Chymases; Dogs; Heart Ventricles; Hemodynamics; Magnetic Resonance Imaging, Cine; Mitral Valve Insufficiency; Myocardium; Peptidyl-Dipeptidase A; Serine Endopeptidases	1995
Increased vascular collagen and noncollagenous protein synthesis contributes to sustain chronic phase of two-kidney, one-clip renovascular hypertension. The Journal of urology, 1996, Volume: 156, Issue:3 Topics: Acute Disease; Angiotensin II; Animals; Chronic Disease; Collagen; Hypertension, Renovascular; Male; Rats; Rats, Wistar; Renin	1996
Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency. The American journal of physiology, 1996, Volume: 271, Issue:1 Pt 2 Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Chlorisondamine; Chronic Disease; Dose-Response Relationship, Drug; Ganglionic Blockers; Hypertension; Imidazoles; Losartan; Male; Nervous System Physiological Phenomena; Rats; Rats, Sprague-Dawley; Tetrazoles	1996
Cardiac angiotensin converting enzyme and endothelin receptor in rats with chronic myocardial infarction. Japanese circulation journal, 1996, Volume: 60, Issue:12 Topics: Angiotensin II; Animals; Autoradiography; Cardiomegaly; Chronic Disease; Endothelin-1; Female; Heart Failure; Image Processing, Computer-Assisted; Iodine Radioisotopes; Ligation; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptors, Endothelin; Renin; Ventricular Function, Left	1996
Plasma levels of atrial natriuretic peptide and of other vasoconstricting hormones in patients with chronic heart failure: relationship to exercise capacity. International journal of cardiology, 1996, Dec-06, Volume: 57, Issue:2 Topics: Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Chronic Disease; Epinephrine; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Prognosis; Radioimmunoassay; Renin; Sensitivity and Specificity; Severity of Illness Index; Vasoconstrictor Agents; Vasopressins	1996
The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1997, Volume: 29, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chronic Disease; Extracellular Matrix Proteins; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Imidazoles; Kidney; Lisinopril; Male; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Plasma Flow; Tetrazoles; Transforming Growth Factor beta	1997
Role of nitric oxide in modulating the chronic renal and arterial pressure responses to angiotensin II. American journal of hypertension, 1997, Volume: 10, Issue:2 Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Chronic Disease; Dogs; Enzyme Inhibitors; Glomerular Filtration Rate; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Renal Plasma Flow; Vasoconstrictor Agents	1997
Low dose angiotensin II infusions into the renal artery induce chronic hypertension in conscious dogs. Blood pressure, 1997, Volume: 6, Issue:1 Topics: Angiotensin II; Animals; Chronic Disease; Dogs; Dose-Response Relationship, Drug; Hypertension, Renal; Infusions, Intra-Arterial; Infusions, Intravenous; Pilot Projects; Renal Artery; Renal Circulation; Sodium Chloride; Vascular Resistance; Vasoconstrictor Agents; Water	1997
Vasoactive hormones in uraemic patients with chronic hypotension. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1997, Volume: 12, Issue:2 Topics: Adult; Aged; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Catecholamines; Chronic Disease; Female; Humans; Hypotension; Male; Middle Aged; Parathyroid Hormone; Renin; Uremia	1997
Central ANG II receptor involved in carotid sinus reflex resetting in chronically stressed rats. Physiology & behavior, 1997, Volume: 62, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Baroreflex; Blood Pressure; Brain Chemistry; Carotid Sinus; Chronic Disease; Injections, Intraventricular; Male; Rats; Rats, Wistar; Receptors, Angiotensin; Saralasin; Stress, Psychological; Vasoconstrictor Agents	1997
Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits. The American journal of pathology, 1997, Volume: 151, Issue:6 Topics: Angiotensin II; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Chronic Disease; Creatinine; Cyclosporine; Gene Expression Regulation; Immunoenzyme Techniques; Immunosuppressive Agents; Kidney Diseases; Kidney Tubules; Male; Rats; Rats, Sprague-Dawley; Urea	1997
Angiotensin II and endothelin in chronic glomerulonephritis. Kidney international, 1998, Volume: 54, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Endothelin-1; Glomerulonephritis; Rats	1998
AT1 receptors mediate chronic central nervous system AII hypertension in rats fed high sodium chloride diet from weaning. Journal of the autonomic nervous system, 1998, Aug-06, Volume: 72, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Central Nervous System Diseases; Chronic Disease; Diet, Sodium-Restricted; Hypertension; Injections, Intraventricular; Losartan; Natriuresis; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Weaning	1998
Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats. Journal of hypertension, 1998, Volume: 16, Issue:8 Topics: Acute Disease; Adrenergic alpha-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chronic Disease; Denervation; Enzyme Inhibitors; Hypertension; Injections, Intravenous; Injections, Intraventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phentolamine; Rats; Rats, Wistar; Sinoatrial Node; Tetrazoles	1998
Effects of vasoactive agents in healthy and diseased human saphenous veins. Journal of vascular surgery, 1998, Volume: 28, Issue:5 Topics: Angiotensin II; Chronic Disease; Endothelin-1; Female; Humans; In Vitro Techniques; Male; Middle Aged; Muscle, Smooth, Vascular; Norepinephrine; Saphenous Vein; Vasoconstrictor Agents; Venous Insufficiency	1998
Role of angiotensin II in hyperinsulinemia-induced hypertension in rats. Journal of hypertension, 1998, Volume: 16, Issue:12 Pt 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Chronic Disease; Fosinopril; Hyperinsulinism; Hypertension; Insulin; Kidney; Losartan; Male; Rats; Rats, Sprague-Dawley	1998
Drinking and blood pressure during sodium depletion or ANG II infusion in chronic cholestatic rats. The American journal of physiology, 1999, Volume: 276, Issue:1 Topics: Angiotensin II; Animals; Appetite; Blood Pressure; Body Weight; Cholestasis; Chronic Disease; Common Bile Duct; Diuretics; Dose-Response Relationship, Drug; Drinking; Furosemide; Infusions, Intravenous; Ligation; Male; Rats; Rats, Long-Evans; Sodium; Sodium Chloride	1999
Regulation of sympathetic nerve activity in heart failure: a role for nitric oxide and angiotensin II. Circulation research, 1999, Mar-05, Volume: 84, Issue:4 Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output, Low; Cardiac Pacing, Artificial; Chronic Disease; Hemodynamics; Kidney; Losartan; Male; Myocardium; Nitric Oxide; Nitroprusside; Organ Size; Rabbits; Reference Values; Sympathetic Nervous System	1999
Alpha-adrenergic systems mediate chronic central AII hypertension in rats fed high sodium chloride diet from weaning. Journal of the autonomic nervous system, 1999, Apr-16, Volume: 76, Issue:1 Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Blood Pressure; Brain; Chronic Disease; Diet; Hypertension; Injections, Intraventricular; Natriuresis; Phentolamine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Sodium Chloride; Weaning	1999
Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:2 Topics: Adrenal Medulla; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Chemoreceptor Cells; Chromatography, High Pressure Liquid; Chronic Disease; Circadian Rhythm; Data Interpretation, Statistical; Denervation; Hemodynamics; Hypertension; Hypoxia; Kidney; Losartan; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Recurrence; Renal Artery; Renin; Renin-Angiotensin System; Sleep Apnea Syndromes; Sympathetic Nervous System; Time Factors	1999
Chronic hypoxia alters effects of endothelin and angiotensin on K+ currents in pulmonary arterial myocytes. The American journal of physiology, 1999, Volume: 277, Issue:3 Topics: Angiotensin II; Animals; Chronic Disease; Electric Conductivity; Endothelin-1; Heart Ventricles; Hypoxia; Male; Muscle, Smooth, Vascular; Myocardium; Organ Size; Potassium Channels; Pulmonary Artery; Rats; Rats, Wistar	1999
Effects of the angiotensin II antagonist losartan on endothelin-1 and norepinephrine plasma levels during cold pressor test in patients with chronic heart failure. International journal of cardiology, 1999, Aug-31, Volume: 70, Issue:3 Topics: Aged; Aged, 80 and over; Angiotensin II; Antihypertensive Agents; Blood Pressure; Chronic Disease; Cold Temperature; Endothelin-1; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Losartan; Male; Middle Aged; Norepinephrine; Sympathetic Nervous System; Vasoconstriction	1999
Comment on "Effects of long-term angiotensin II AT-1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats". Cardiovascular research, 1999, Aug-01, Volume: 43, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Chronic Disease; Heart Failure; Irbesartan; Rats; Tetrazoles	1999
Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure. Journal of cardiovascular pharmacology, 2000, Volume: 36, Issue:4 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiac Output; Chronic Disease; Echocardiography; Female; Heart; Heart Failure; Imidazoles; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Organ Size; Ramipril; Stroke Volume; Tetrazoles; Ventricular Remodeling	2000
Important role of angiotensin II-mediated c-Jun NH(2)-terminal kinase activation in cardiac hypertrophy in hypertensive rats. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:4 Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Binding, Competitive; Blood Pressure; Cardiomegaly; Chronic Disease; DNA; Heart Rate; Hypertension; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Organ Size; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Transcription Factor AP-1	2000
Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients. The Journal of laboratory and clinical medicine, 2000, Volume: 136, Issue:5 Topics: Acid-Base Equilibrium; Acidosis; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Chronic Disease; Electrolytes; Female; Humans; Hydrocortisone; Losartan; Male; Nitrogen; Spironolactone	2000
Acute AT1 receptor blockade does not improve the depressed baroreflex in rats with chronic renal hypertension. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2000, Volume: 33, Issue:12 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Baroreflex; Bradycardia; Chronic Disease; Heart Rate; Hypertension, Renal; Losartan; Male; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tachycardia	2000
Chronic hypoxia induced down-regulation of angiotensinogen expression in rat epididymis. Regulatory peptides, 2001, Jan-12, Volume: 96, Issue:3 Topics: Angiotensin II; Angiotensinogen; Animals; Blotting, Western; Chronic Disease; Down-Regulation; Epididymis; Hypoxia; In Situ Hybridization; Male; Oligonucleotides, Antisense; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2001
Chronic hypoxia upregulates the expression and function of AT(1) receptor in rat carotid body. The Journal of endocrinology, 2000, Volume: 167, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Carotid Body; Chemoreceptor Cells; Chronic Disease; Electrophysiology; Female; Gene Expression Regulation; Hypoxia; Immunohistochemistry; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2000
AT(1) receptor blockers prevent sympathetic hyperactivity and hypertension by chronic ouabain and hypertonic saline. American journal of physiology. Heart and circulatory physiology, 2001, Volume: 280, Issue:3 Topics: Air Movements; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Cardiotonic Agents; Chronic Disease; Guanabenz; Heart Rate; Hypertension; Injections, Intraventricular; Losartan; Male; Ouabain; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Saline Solution, Hypertonic; Stress, Physiological; Sympathetic Nervous System; Vasoconstrictor Agents	2001
Antisense inhibition of brain renin-angiotensin system decreased blood pressure in chronic 2-kidney, 1 clip hypertensive rats. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:2 Pt 2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Blood Pressure; Brain; Chronic Disease; Hypertension; Hypertension, Renovascular; Hypothalamus; Injections, Intraventricular; Male; Oligonucleotides, Antisense; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Time Factors	2001
Effect of chronic hypoxia on agonist-induced tone and calcium signaling in rat pulmonary artery. American journal of physiology. Lung cellular and molecular physiology, 2001, Volume: 281, Issue:1 Topics: Adenosine Triphosphate; Angiotensin II; Animals; Caffeine; Calcium; Calcium Signaling; Chronic Disease; Endothelin-1; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; In Vitro Techniques; Indoles; Intracellular Membranes; Male; Muscle, Smooth, Vascular; Pulmonary Artery; Rats; Rats, Wistar; Reference Values; Vasoconstriction; Vasodilator Agents; Vasomotor System	2001
Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation, 2001, Jul-17, Volume: 104, Issue:3 Topics: Angiotensin II; Animals; Chronic Disease; Collagen; Diastole; Disease Models, Animal; Echocardiography; Echocardiography, Doppler; Endomyocardial Fibrosis; Fibronectins; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Systole; Transforming Growth Factor beta; Transforming Growth Factor beta1	2001
Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure. British journal of pharmacology, 2001, Volume: 134, Issue:1 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Chronic Disease; Collagen; Dose-Response Relationship, Drug; Fibroblasts; GTP-Binding Proteins; Heart; Heart Failure; Heart Septum; Heart Ventricles; Hemodynamics; Imidazoles; Indoles; Lung; Male; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles	2001
Angiotensin I-converting enzyme gene polymorphism influences chronic hypertensive response in the rat Goldblatt model. Journal of hypertension, 2002, Volume: 20, Issue:3 Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Chronic Disease; Female; Hypertension, Renovascular; Male; Myocardium; Organ Size; Osmolar Concentration; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Rats; Rats, Inbred BN; Rats, Inbred Lew; Renin; Species Specificity; Systole; Ventricular Function, Left	2002
Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone. Journal of endocrinological investigation, 2002, Volume: 25, Issue:5 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Cardiomegaly; Cardiovascular System; Chronic Disease; Enalapril; Losartan; Male; Mesenteric Arteries; Myocardial Infarction; Rats; Rats, Wistar	2002
Renal endothelin in chronic angiotensin II hypertension. American journal of physiology. Regulatory, integrative and comparative physiology, 2002, Volume: 283, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Chronic Disease; Diet, Sodium-Restricted; Endothelins; Hypertension; Kidney; Male; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents	2002
Differential regulation of elevated renal angiotensin II in chronic renal ischemia. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:1 Topics: Angiotensin I; Angiotensin II; Animals; Chronic Disease; Chymases; Cilazapril; Dogs; Hemodynamics; Hypertension, Renal; Imidazoles; Ischemia; Kidney; Male; Oligopeptides; Olmesartan Medoxomil; Peptidyl-Dipeptidase A; Renal Circulation; Renin-Angiotensin System; Serine Endopeptidases; Tetrazoles	2002
Differential diagnosis of hypertension in pregnancy. Clinics in obstetrics and gynaecology, 1977, Volume: 4, Issue:3 Topics: Ambulatory Care; Angiotensin II; Blood Pressure; Chronic Disease; Dehydroepiandrosterone; Diagnosis, Differential; Female; Hospitalization; Humans; Hypertension; Metabolic Clearance Rate; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Stimulation, Chemical	1977
Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. The American journal of medicine, 1975, Volume: 59, Issue:3 Topics: Adult; Age Factors; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arginine; Blood Pressure; Carboxypeptidases; Chronic Disease; Edetic Acid; Female; Hippurates; Humans; Lung Diseases; Male; Middle Aged; Oligopeptides; Peptidyl-Dipeptidase A; Prednisone; Sarcoidosis; Sex Factors; Teprotide	1975
The inhibition of angiotensin converting enzyme in chronic renal hypertension by a synthetic peptide. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1975, Volume: 150, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chronic Disease; Hypertension, Renal; Injections, Subcutaneous; Male; Nephrectomy; Peptides; Rats; Renin; Time Factors; Venoms	1975
[Laboratory diagnosis of renal diseases. XXI. Renal hypertension]. Przeglad lekarski, 1975, Volume: 32, Issue:2 Topics: Acute Disease; Angiotensin II; Blood Vessels; Chronic Disease; Glomerulonephritis; Humans; Hypertension, Renal; Kidney; Kidney Neoplasms; Pyelonephritis; Renin; Sodium; Sympathetic Nervous System; Urography	1975
[Dopamine 17-beta-hydroxylase in chronic uremic patients under periodic hemodialytic treatment]. Chirurgia e patologia sperimentale, 1979, Volume: 27, Issue:6 Topics: Angiotensin II; Chronic Disease; Dopamine beta-Hydroxylase; Humans; Renal Dialysis; Renin; Uremia	1979
The pressor actions of noradrenaline, angiotensin II and saralasin in chronic autonomic failure treated with fludrocortisone. British journal of clinical pharmacology, 1979, Volume: 8, Issue:3 Topics: Aged; Angiotensin II; Autonomic Nervous System; Blood Pressure; Chronic Disease; Female; Fludrocortisone; Humans; Male; Middle Aged; Nervous System Diseases; Norepinephrine; Phentolamine; Saralasin	1979
Effects of angiotensen antagonist in rats with acute, subacute, and chronic two-kidney renal hypertension. The Journal of laboratory and clinical medicine, 1978, Volume: 91, Issue:2 Topics: Acute Disease; Angiotensin II; Animals; Chronic Disease; Hypertension, Renal; Male; Rats; Renin; Saralasin	1978
Existence of a new vasoactive factor in experimental hypertension. The American journal of physiology, 1978, Volume: 234, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Chronic Disease; Dogs; Dose-Response Relationship, Drug; Hypertension, Renal; Male; Molecular Weight; Norepinephrine; Rats; Renin	1978
Renal vein renin concentration in the hypertension of unilateral reflux nephropathy. The Journal of urology, 1978, Volume: 120, Issue:1 Topics: Angiotensin II; Chronic Disease; Female; Humans; Hypertension, Renal; Male; Pyelonephritis; Renal Veins; Renin	1978
[State of the renin-angiotensin-aldosterone system in chronic circulatory insufficiency]. Terapevticheskii arkhiv, 1978, Volume: 50, Issue:6 Topics: Aldosterone; Angiotensin II; Chronic Disease; Coronary Disease; Humans; Renin	1978
Renal hemodynamics in acute and chronic angiotensin II hypertension. The American journal of physiology, 1978, Volume: 235, Issue:3 Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Body Fluids; Chronic Disease; Dogs; Glomerular Filtration Rate; Hemodynamics; Hypertension, Renal; Kidney; Male	1978
Hypertensive and renal effects of chronic low level intrarenal angiotensin infusion in the dog. Circulation research, 1979, Volume: 44, Issue:2 Topics: Angiotensin II; Animals; Blood Pressure; Chronic Disease; Dogs; Hematocrit; Hypertension, Renal; Infusions, Parenteral; Kidney Function Tests; Potassium; Renin; Sodium	1979
A prospective study of angiotensin II pressor responsiveness in pregnancies complicated by chronic essential hypertension. American journal of obstetrics and gynecology, 1977, Feb-15, Volume: 127, Issue:4 Topics: Angiotensin II; Chronic Disease; Female; Humans; Hypertension; Pregnancy; Pregnancy Complications, Cardiovascular; Prognosis; Prospective Studies; Vasomotor System	1977
Intrarenal renin-angiotensin-sodium interdependent mechanism controlling postclamp renal artery pressure and renin release in the conscious dog with chronic one-kidney Goldblatt hypertension. Circulation research, 1977, Volume: 40, Issue:3 Topics: Angiotensin II; Animals; Blood Pressure; Chronic Disease; Disease Models, Animal; Dogs; Feedback; Female; Hypertension, Renal; Renal Artery Obstruction; Renin; Sodium; Vascular Resistance	1977
The role of intrarenal angiotensin II in the hemodynamic response to unilateral obstructive uropathy. Investigative urology, 1977, Volume: 14, Issue:5 Topics: Acute Disease; Angiotensin II; Animals; Chronic Disease; Dogs; Female; Glomerular Filtration Rate; Kidney; Regional Blood Flow; Renin; Saralasin; Ureteral Obstruction; Vascular Resistance	1977
Relationship between aldosterone and bradykinin. Circulation research, 1977, Volume: 40, Issue:5 Suppl 1 Topics: Adrenal Insufficiency; Adult; Aldosterone; Angiotensin II; Bradykinin; Chronic Disease; Humans; Middle Aged; Potassium; Renin; Teprotide	1977
Studies on plasma vasopressin and the renin-angiotensin-aldosterone system in chronic obstructive lung disease. The Journal of laboratory and clinical medicine, 1977, Volume: 90, Issue:2 Topics: Aldosterone; Angiotensin II; Arginine Vasopressin; Carbon Dioxide; Chronic Disease; Humans; Kidney; Lung Diseases, Obstructive; Osmolar Concentration; Renin; Sodium; Vasopressins; Water	1977
Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis. Kidney international, 1976, Volume: 9, Issue:6 Topics: Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Humans; Liver Cirrhosis; Renin; Saralasin	1976
[Influence of indomethacin on the course of glomerulonephritis]. La Nouvelle presse medicale, 1976, Nov-13, Volume: 5, Issue:38 Topics: Adult; Angiotensin II; Chronic Disease; Female; Glomerulonephritis; Humans; Indomethacin; Proteinuria	1976
Therapy and prognosis of hypertension in chronic nephritis. Japanese circulation journal, 1975, Volume: 39, Issue:7 Topics: Adult; Aldosterone; Angiotensin II; Blood Volume; Catecholamines; Chronic Disease; Creatinine; Extracellular Space; Female; Glomerulonephritis; Humans; Hydralazine; Hypertension; Hypertension, Renal; Male; Methyldopa; Middle Aged; Prognosis; Propranolol	1975
Indirect blood pressure measurements in the rabbit: correlations with direct aortic and ear pressures. The Journal of laboratory and clinical medicine, 1975, Volume: 86, Issue:6 Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Blood Pressure Determination; Cadmium; Chronic Disease; Ear, External; Female; Hypertension; Hypertension, Renal; Male; Rabbits	1975
[Renin-angiotensin-aldosterone system in hypertensive disease and arteriosclerotic myocardioslcerosis complicated by chronic circulatory insufficiency]. Vrachebnoe delo, 1975, Issue:7 Topics: Aged; Aldosterone; Angiotensin II; Blood Circulation; Chronic Disease; Coronary Disease; Female; Humans; Hypertension; Male; Middle Aged; Renin	1975
[State of the renin-angiotensin system in acute and chronic circulatory insufficiency]. Vrachebnoe delo, 1975, Issue:8 Topics: Acute Disease; Angiotensin II; Blood Circulation; Chronic Disease; Coronary Disease; Hemodynamics; Humans; Renin	1975
[Involvement of the Renin-angiotensin system in experimental hyper-tensions, demonstrated by a new specific angiotensin II antagonist]. Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung, 1975, Volume: 41 Topics: Acute Disease; Angiotensin II; Animals; Chronic Disease; Hypertension, Renal; Male; Rats; Renin	1975
Transpulmonary angiotensin II formation and pulmonary haemodynamics in stable hypoxic lung disease: the effect of captopril. Respiratory medicine, 1992, Volume: 86, Issue:1 Topics: Aged; Angiotensin II; Blood Pressure; Captopril; Cardiac Output; Chronic Disease; Female; Humans; Hypoxia; Lung; Male; Middle Aged; Pulmonary Gas Exchange; Renin; Vascular Resistance	1992
Disturbance in sodium regulating hormones in chronic obstructive uropathy. British journal of urology, 1991, Volume: 68, Issue:2 Topics: Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Chronic Disease; Diuresis; Humans; Middle Aged; Renin; Ureteral Obstruction; Urinary Catheterization; Urinary Retention	1991
Glomerular binding and contractile response to angiotensin II in rats with chronic experimental cirrhosis of the liver. Clinical science (London, England : 1979), 1991, Volume: 80, Issue:2 Topics: Angiotensin II; Animals; Chronic Disease; Glomerular Filtration Rate; Kidney; Kidney Glomerulus; Liver Cirrhosis, Experimental; Male; Rats; Rats, Inbred Strains; Regional Blood Flow	1991
Attentuation of systemic vasoreactivity in chronically hypoxic rats. The American journal of physiology, 1991, Volume: 260, Issue:6 Pt 2 Topics: Angiotensin II; Animals; Aorta; Arginine Vasopressin; Blood Pressure; Cardiac Output; Chronic Disease; Consciousness; Dose-Response Relationship, Drug; Hypoxia; Male; Oxygen; Phenylephrine; Rats; Rats, Inbred Strains; Vasoconstriction; Vasodilation	1991
Chronic hyperinsulinemia and blood pressure regulation. The American journal of physiology, 1990, Volume: 258, Issue:3 Pt 2 Topics: Angiotensin II; Animals; Blood Pressure; Chronic Disease; Diet; Dogs; Hyperinsulinism; Hypertension; Insulin; Sodium	1990
[A case report of high plasma renin activity in chronic pulmonary disease and the effect of angiotensin-II-analogue (1-sarcosine, 8-isoleucine-angiotensin-II)]. Nihon Kyobu Shikkan Gakkai zasshi, 1990, Volume: 28, Issue:4 Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin I; Angiotensin II; Blood Pressure; Chronic Disease; Female; Humans; Lung Diseases; Male; Renin	1990
Conceptual and therapeutic approaches to inhibition of the renin-angiotensin system in chronic heart failure. Journal of cardiovascular pharmacology, 1986, Volume: 8 Suppl 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Enalapril; Enalaprilat; Enzyme Activation; Heart Failure; Heart Rate; Hemodynamics; Humans; Renin-Angiotensin System; Saralasin; Sodium; Vasoconstriction	1986
Changes in the renin-angiotensin-aldosterone system in rats of both sexes submitted to chronic hypobaric hypoxia. Archives internationales de physiologie et de biochimie, 1987, Volume: 95, Issue:4 Topics: Aldosterone; Altitude; Angiotensin II; Animals; Atmospheric Pressure; Blood Pressure; Chronic Disease; Female; Gonadal Steroid Hormones; Hematocrit; Hypoxia; Male; Orchiectomy; Ovariectomy; Rats; Renin	1987
Renin regulation in type II diabetes mellitus: influence of dietary sodium. Hypertension (Dallas, Tex. : 1979), 1989, Volume: 13, Issue:3 Topics: Aged; Angiotensin II; Chronic Disease; Creatinine; Diabetes Mellitus, Type 2; Humans; Hypertension; Middle Aged; Potassium; Renin; Renin-Angiotensin System; Sodium; Sodium, Dietary; Time Factors	1989
Meclofenamate potentiates vasoreactivity to alpha-adrenergic stimulation in chronically hypoxic guinea pigs. The American journal of physiology, 1986, Volume: 251, Issue:3 Pt 2 Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Aorta; Chronic Disease; Drug Synergism; Guinea Pigs; Hypoxia; In Vitro Techniques; Meclofenamic Acid; ortho-Aminobenzoates; Phenylephrine; Stimulation, Chemical; Vascular Resistance	1986
Does chronic hyperinsulinemia cause hypertension? American journal of hypertension, 1989, Volume: 2, Issue:3 Pt 1 Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Chronic Disease; Dogs; Hyperinsulinism; Hypertension; Natriuresis; Obesity	1989
Chronic hypotensive effects of verapamil in angiotensin hypertension are steroid independent. Hypertension (Dallas, Tex. : 1979), 1989, Volume: 13, Issue:3 Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Chronic Disease; Dogs; Drug Evaluation, Preclinical; Hypertension; Kidney; Male; Verapamil; Water-Electrolyte Balance	1989
Sustained release verapamil in renal hypertension. European journal of clinical pharmacology, 1988, Volume: 33, Issue:6 Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Delayed-Action Preparations; Female; Humans; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Verapamil	1988
Atrial natriuretic peptide, angiotensin II and aldosterone in plasma in chronic glomerulonephritis during basal conditions and during exercise. Acta medica Scandinavica, 1988, Volume: 224, Issue:1 Topics: Adult; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Exercise Test; Glomerulonephritis; Heart Rate; Humans; Male; Middle Aged; Potassium	1988
Increased atrial natriuretic peptide in an early stage of chronic glomerulonephritis. Scandinavian journal of clinical and laboratory investigation, 1988, Volume: 48, Issue:4 Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Chronic Disease; Female; Glomerular Filtration Rate; Glomerulonephritis; Humans; Male; Middle Aged; Prostaglandins E; Saline Solution, Hypertonic; Sodium	1988
[Acute and long-term effect of captopril in severe chronic heart failure]. Deutsche medizinische Wochenschrift (1946), 1985, Apr-12, Volume: 110, Issue:15 Topics: Adult; Aged; Angiotensin I; Angiotensin II; Captopril; Chronic Disease; Drug Evaluation; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Proline; Time Factors	1985
Impaired pulmonary conversion of angiotensin I to angiotensin II in rats exposed to chronic hypoxia. Journal of applied physiology (Bethesda, Md. : 1985), 1986, Volume: 60, Issue:4 Topics: Angiotensin I; Angiotensin II; Angiotensins; Animals; Chronic Disease; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Lung; Male; Peptidyl-Dipeptidase A; Perfusion; Pulmonary Circulation; Rats; Rats, Inbred Strains	1986
Relationship of angiotensin II, aldosterone, arginine vasopressin, adrenaline and noradrenaline in plasma, blood and extracellular volumes to blood pressure in chronic glomerulonephritis. European journal of clinical investigation, 1986, Volume: 16, Issue:1 Topics: Adolescent; Adult; Angiotensin II; Arginine Vasopressin; Blood Pressure; Blood Volume; Chronic Disease; Creatinine; Epinephrine; Extracellular Space; Female; Glomerulonephritis; Hormones; Humans; Hypertension; Male; Middle Aged; Norepinephrine	1986
Angiotensin II-noradrenergic interactions in renovascular hypertensive rats. The Journal of clinical investigation, 1987, Volume: 80, Issue:2 Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Electric Stimulation; Hypertension, Renovascular; Norepinephrine; Rats; Renal Artery; Renin; Sympathetic Nervous System; Vascular Resistance	1987
Angiotensin II prevents hypoxic pulmonary hypertension and vascular changes in rat. The American journal of physiology, 1988, Volume: 254, Issue:3 Pt 2 Topics: Acute Disease; Angiotensin II; Animals; Blood Vessels; Chronic Disease; Hypertension, Pulmonary; Hypoxia; Infusions, Intravenous; Male; Pulmonary Circulation; Rats; Rats, Inbred Strains	1988
Effect of chronic hypokalaemia on renal concentrating ability and secretion of arginine vasopressin. Scandinavian journal of clinical and laboratory investigation, 1987, Volume: 47, Issue:1 Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Bartter Syndrome; Chronic Disease; Female; Follow-Up Studies; Humans; Hypokalemia; Kidney Concentrating Ability; Kidney Tubules; Male; Middle Aged	1987
Adrenergic and angiotensin II influences on renal vascular tone in chronic sodium depletion. The American journal of physiology, 1987, Volume: 252, Issue:5 Pt 2 Topics: Angiotensin II; Animals; Chronic Disease; Denervation; Glomerular Filtration Rate; Hemodynamics; Kidney; Male; Muscle Tonus; Rats; Rats, Inbred Strains; Renal Circulation; Sodium; Sympathetic Nervous System; Vasomotor System	1987
Angiotensin II, aldosterone and arginine-vasopressin in exaggerated natriuresis of chronic glomerulonephritis. Acta medica Scandinavica. Supplementum, 1985, Volume: 693 Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Chronic Disease; Glomerulonephritis; Humans; Middle Aged; Natriuresis; Osmolar Concentration; Sodium	1985
Role of mesangial proliferation in angiotensin II and antidiuretic hormone induced changes in glomerular filtration rate. Japanese circulation journal, 1985, Volume: 49, Issue:11 Topics: Adult; Angiotensin II; Blood Pressure; Chronic Disease; Creatinine; Glomerular Filtration Rate; Glomerular Mesangium; Glomerulonephritis; Humans; Kidney Function Tests; Male; Natriuresis; Urine; Vasopressins	1985
[Blood plasma content of angiotensinogen in arterial hypertension, circulatory insufficiency, myocardial infarct and liver cirrhosis]. Kardiologiia, 1972, Volume: 12, Issue:2 Topics: Adrenal Glands; Alpha-Globulins; Angiotensin II; Chronic Disease; Glomerulonephritis; Glucocorticoids; Heart Failure; Humans; Hypertension; Liver; Liver Cirrhosis; Myocardial Infarction; Renin	1972
Measurement of concentrations of angiotensin I in human blood by radioimmunoassay. Clinical science, 1973, Volume: 45, Issue:1 Topics: Alpha-Globulins; Angiotensin II; Animals; Arteries; Blood Preservation; Blood Specimen Collection; Chemical Precipitation; Chromatography, Ion Exchange; Chronic Disease; Ethanol; Humans; Immunization; Iodine Isotopes; Kidney Failure, Chronic; Methods; Nephrectomy; Rabbits; Radioimmunoassay; Renin; Veins	1973
Antihypertensive effect of an isolated phospholipid. The American journal of physiology, 1968, Volume: 214, Issue:2 Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Depression, Chemical; Hypertension, Renal; Intestinal Absorption; Kidney; Nephrectomy; Phospholipids; Rats; Renin	1968
Production of Arneil-Dekanski factor in vitro by plasma of renal hypertensive rats. European journal of pharmacology, 1968, Volume: 3, Issue:1 Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Hypertension, Renal; Kidney; Male; Nephrectomy; Plasma; Rats; Renal Artery; Vasoconstrictor Agents	1968
Angiotensin-infusion test. Correlation with renin activity in peripheral venous blood. Archives of internal medicine, 1968, Volume: 122, Issue:1 Topics: Adult; Angiotensin II; Chronic Disease; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Kidney Diseases; Male; Renin; Veins	1968
[Behavior of the kallikrein-bradykinin system in the course of blood pressure increases]. Studii si cercetari de fiziologie, 1968, Volume: 13, Issue:2 Topics: Adolescent; Adult; Angiotensin II; Bradykinin; Chronic Disease; Female; Humans; Hypertension; Infusions, Parenteral; Kallikreins; Male; Middle Aged	1968
[On the effect of kinin-hormones on the mechanism of urine dilution and urine concentration. II. Studies during hydropenia and eliguria as well as during osmotic diuresis with hypertonic mannitol solutions]. Arzneimittel-Forschung, 1967, Volume: 17, Issue:4 Topics: Adolescent; Adult; Aminohippuric Acids; Angiotensin II; Anuria; Bradykinin; Chronic Disease; Depression, Chemical; Diuresis; Eledoisin; Female; Glomerulonephritis; Humans; Hypertonic Solutions; Inulin; Kidney; Kidney Concentrating Ability; Male; Mannitol; Middle Aged; Pyelonephritis; Sodium; Stimulation, Chemical	1967
Assay of plasma angiotensin. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1968, Nov-23, Volume: 42, Issue:45 Topics: Angiotensin II; Chronic Disease; Humans; Hypertension, Renal; Nephritis; Renal Artery Obstruction	1968
Chronic laxative-induced hyperaldosteronism and hypokalemia simulating Bartter's syndrome. Annals of internal medicine, 1969, Volume: 70, Issue:4 Topics: Aldosterone; Angiotensin II; Blood Glucose; Blood Proteins; Blood Urea Nitrogen; Blood Volume Determination; Body Weight; Calcium; Cathartics; Chronic Disease; Diagnosis, Differential; Female; Hematocrit; Humans; Hyperaldosteronism; Hypokalemia; Insulin; Juxtaglomerular Apparatus; Kidney Diseases; Kidney Glomerulus; Middle Aged; Plasma Volume; Posture; Potassium; Renin; Sodium; Substance-Related Disorders	1969
Metanephrine: cardiovascular responsiveness in normotensive and renal hypertensive dogs. European journal of pharmacology, 1969, Volume: 5, Issue:3 Topics: Adrenalectomy; Angiotensin II; Animals; Blood Pressure; Catecholamines; Chronic Disease; Dogs; Hypertension, Renal; Male; Nephrectomy; Pentolinium Tartrate; Phenethylamines; Phentolamine; Renin	1969
Renin release from ischemic kidneys following angiotensin infusion in dogs. Japanese circulation journal, 1969, Volume: 33, Issue:3 Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Chronic Disease; Denervation; Dogs; Female; Hypertension, Renal; Injections, Intravenous; Ischemia; Kidney; Male; Renal Artery Obstruction; Renin; Stimulation, Chemical	1969
[Study on the renin-angiotensin-aldosterone system. Evaluation of the dynamics of renal renin and adrenal cortex aldosterone production in the chronic stage of Goldblatt's rats]. Japanese circulation journal, 1967, Volume: 31, Issue:11 Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Blood Pressure; Chromatography, Thin Layer; Chronic Disease; Histocytochemistry; Hypertension, Renal; Hypertrophy; Kidney; Male; Microscopy, Electron; Rats; Renal Artery; Renin	1967
[Renin-angiotensin system in pathology]. Les Cahiers du College de medecine des hopitaux de Paris, 1968, Volume: 9, Issue:1 Topics: Adrenal Gland Diseases; Angiotensin II; Chronic Disease; Edema; Female; Humans; Hypertension; Hyponatremia; Kidney Diseases; Male; Pregnancy; Renin	1968
[Results of angiotensin infusion test in renovascular hypertension and other forms of hypertension]. Klinische Wochenschrift, 1969, Apr-01, Volume: 47, Issue:7 Topics: Adolescent; Adult; Angiotensin II; Blood Pressure; Chronic Disease; Diagnosis, Differential; Female; Humans; Hypertension; Hypertension, Malignant; Hypertension, Renal; Male; Middle Aged; Prognosis; Renal Artery Obstruction	1969
Plasma renin activity and the effects of deoxycorticosterone acetate in dogs with chronic left ventricular overload. Circulation research, 1970, Volume: 27, Issue:5 Topics: Acetates; Angiotensin II; Animals; Aorta, Thoracic; Chronic Disease; Desoxycorticosterone; Disease Models, Animal; Dogs; Heart; Heart Atria; Heart Failure; Methods; Natriuresis; Pulmonary Edema; Renin	1970
[Study of the plasmatic renin and reno-medullin in chronic uremic patients during extracorporeal hemodialytic treatment]. Minerva medica, 1970, Nov-17, Volume: 61, Issue:92 Topics: Angiotensin II; Chronic Disease; Endopeptidases; Humans; Kidney Failure, Chronic; Renal Dialysis; Renin; Uremia; Vasoconstrictor Agents; Vasodilator Agents	1970
[Internal therapy of peripheral arterial blood circulation disorders]. Schweizerische medizinische Wochenschrift, 1970, May-02, Volume: 100, Issue:18 Topics: Adenosine Triphosphate; Aged; Angiotensin II; Anti-Bacterial Agents; Blood Pressure; Chlorpromazine; Chronic Disease; Collateral Circulation; Coumarins; Epinephrine; Ergot Alkaloids; Exercise Therapy; Femoral Artery; Fibrinolytic Agents; Humans; Infusions, Parenteral; Male; Methoxamine; Nicotinic Acids; Papaverine; Popliteal Artery; Propranolol; Reserpine; Sympatholytics; Sympathomimetics; Thrombosis; Vascular Diseases	1970
Chronic hypertension elicited by infusion of angiotensin into vertebral arteries of unanaesthetized dogs. Clinical science, 1971, Volume: 40, Issue:3 Topics: Angiotensin II; Animals; Aorta, Abdominal; Blood Pressure; Catheterization; Central Nervous System; Chronic Disease; Dogs; Hypertension; Injections, Intra-Arterial; Injections, Intravenous; Jugular Veins; Sleep; Tachyphylaxis; Vertebral Artery; Wakefulness	1971
[Importance of Kaplan's hypertension testing the etiologic diagnosis of hypertension]. Helvetica medica acta. Supplementum, 1966, May-15, Volume: 46 Topics: Angiography; Angiotensin II; Chronic Disease; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Kidney Diseases; Methods; Renal Artery Obstruction; Renin	1966
[Cause of angiotensin resistance in chronic pyelonephritis]. Klinische Wochenschrift, 1970, Dec-01, Volume: 48, Issue:23 Topics: Angiotensin II; Blood Pressure; Chronic Disease; Humans; Hyperaldosteronism; Natriuresis; Norepinephrine; Pyelonephritis; Renin; Water-Electrolyte Balance	1970
[Effect differences between angiotensin II and noradrenalin in reference to diuresis, sodium and potassium excretion in healthy persons and patients with kidney diseases]. Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete, 1970, Volume: 51, Issue:7 Topics: Angiotensin II; Blood Pressure; Chronic Disease; Depression, Chemical; Female; Glomerular Filtration Rate; Glomerulonephritis; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Natriuresis; Norepinephrine; Potassium; Pregnancy; Pregnancy Complications; Pyelonephritis; Stimulation, Chemical	1970
[The epidermolysis syndrome (Lyell) from the viewpoint of internal medicine]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1970, Apr-15, Volume: 25, Issue:8 Topics: Acute Disease; Aged; Angiotensin II; Cardiomegaly; Cholangitis; Chronic Disease; Diabetes Complications; Glomerulonephritis; Humans; Liver Cirrhosis; Male; Methicillin; Middle Aged; Pancreatic Diseases; Potassium; Prednisolone; Prognosis; Stevens-Johnson Syndrome	1970
[Renin activity, angiotensinogen levels and plasma angiotensinase activity in patients with hypertensive diseases of the kidneys]. Kardiologiia, 1971, Volume: 11, Issue:8 Topics: Amyloidosis; Angiotensin II; Chronic Disease; Congenital Abnormalities; Endopeptidases; Glomerulonephritis; Humans; Hypertension, Renal; Kidney; Kidney Diseases; Nephrectomy; Pyelonephritis; Renin; Tuberculosis, Renal	1971
High plasma renin activity and hypokalemia in rabbits with chronic renovascular hypertension. Japanese heart journal, 1972, Volume: 13, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Chronic Disease; Hypertension, Renal; Hypokalemia; Male; Potassium; Rabbits; Renin; Sodium	1972
Changes of blood pressure, renin, and angiotensin after bilateral nephrectomy in patients with chronic renal failure. British medical journal, 1972, Dec-23, Volume: 4, Issue:5842 Topics: Adolescent; Adult; Angiotensin II; Antihypertensive Agents; Blood Pressure; Chronic Disease; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Nephrectomy; Renal Dialysis; Renin	1972
Determination of plasma renin activity by radioimmunoassay of angiotensin I. Clinical science, 1973, Volume: 44, Issue:1 Topics: Adolescent; Adult; Angiotensin II; Animals; Biological Assay; Chronic Disease; Edetic Acid; Glomerulonephritis; Hot Temperature; Humans; Hydrogen-Ion Concentration; Hyperaldosteronism; Hypertension; Hypertension, Renal; Iodine Isotopes; Isoflurophate; Methods; Middle Aged; Rabbits; Radioimmunoassay; Renin; Serum Albumin	1973
[Functional state of the renin-hypertension-aldosterone system in chronic circulatory insufficiency]. Klinicheskaia meditsina, 1972, Volume: 50, Issue:11 Topics: Aldosterone; Angiotensin II; Blood Circulation; Chronic Disease; Hemodynamics; Humans; Renin; Water-Electrolyte Balance	1972
[Effects of a new vasoactive substance on renal hemodynamics]. Minerva medica, 1973, Jul-04, Volume: 64, Issue:5 Topics: Angiotensin II; Bromine; Chronic Disease; Ergolines; Female; Glomerular Filtration Rate; Glomerulonephritis; Hemodynamics; Humans; Injections, Intravenous; Kidney; Male; Nicotinic Acids; Norepinephrine; Regional Blood Flow	1973
[Efficacy and limits of diagnostic procedures in hypertension]. Der Internist, 1974, Volume: 15, Issue:3 Topics: Angiography; Angiotensin II; Biopsy, Needle; Chronic Disease; Diagnosis, Differential; Epinephrine; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Kidney; Kidney Function Tests; Norepinephrine; Pheochromocytoma; Radioisotope Renography; Renal Artery; Renin; Vanilmandelic Acid	1974
[Etiology and pathogenesis of hypertension]. Der Internist, 1974, Volume: 15, Issue:3 Topics: Angiotensin II; Blood Pressure; Blood Volume; Catecholamines; Chronic Disease; Environmental Health; Heart; Hemodynamics; Humans; Hypertension; Hypertension, Malignant; Hypertension, Renal; Kidney; Kidney Failure, Chronic; Pressoreceptors; Renal Artery Obstruction; Renin; Sodium	1974
[Induced hypertension (stages 3 and IV) in patients with chronic peripheral arteriopathy (author's transl)]. Medizinische Klinik, 1974, May-24, Volume: 69, Issue:21 Topics: Adult; Angiotensin II; Arterial Occlusive Diseases; Chronic Disease; Desoxycorticosterone; Humans; Hydrocortisone; Hypertension; Middle Aged; Mineralocorticoids; Pain; Regional Blood Flow; Rest; Steroids, Fluorinated; Sympathectomy; Varicose Ulcer	1974
[Symposium on pathophysiology of congestive heart failure. 1. Relationship of renin-angiotensin-aldosterone system to cardio-renal hemodynamics on chronic congestive heart failure (author's transl)]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1973, Volume: 62, Issue:12 Topics: Aldosterone; Angiotensin II; Chronic Disease; Heart; Heart Failure; Hemodynamics; Humans; Kidney; Renin; Sodium	1973
Pressure response of pulmonary vasculature to vasoconstricting agents. Zeitschrift fur Kardiologie, 1973, Volume: 62, Issue:8 Topics: Adult; Aged; Angiotensin II; Blood Pressure; Chronic Disease; Humans; Lung; Middle Aged; Norepinephrine; Pulmonary Circulation; Pulmonary Heart Disease	1973
Renin, angiotensin II and juxtaglomerular apparatus in liver cirrhosis. Japanese circulation journal, 1974, Volume: 38, Issue:10 Topics: Adult; Aged; Angiotensin II; Ascites; Autopsy; Chronic Disease; Creatinine; Female; Hepatitis; Humans; Juxtaglomerular Apparatus; Liver Cirrhosis; Male; Middle Aged; Radioimmunoassay; Renin	1974
Effect of blockade of angiotensin-I converting enzyme on the blood pressure of renal hypertensive rabbits. Cardiovascular research, 1974, Volume: 8, Issue:5 Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Chronic Disease; Hypertension, Renal; Infusions, Parenteral; Male; Nephrectomy; Peptides; Rabbits; Renal Artery Obstruction	1974
The role of the renin--angiotensin system in experimental renal hypertension in dogs. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1974, Volume: 147, Issue:2 Topics: Alanine; Angiotensin II; Animals; Blood Pressure; Blood Urea Nitrogen; Body Temperature; Chronic Disease; Dogs; Female; Hypertension, Renal; Nephrectomy; Potassium; Renal Artery Obstruction; Renin; Sarcosine; Sodium	1974
[Relationship angiotensine-aldosterone and respiratory function in chronic bronchial disease (author's transl)]. Revista espanola de fisiologia, 1972, Volume: 28, Issue:1 Topics: Aldosterone; Angiotensin II; Blood Volume; Body Height; Body Weight; Bronchopneumonia; Carbon Dioxide; Chronic Disease; Evaluation Studies as Topic; Humans; Oxygen; Partial Pressure; Spirometry	1972
Blood pressure regulation during chronic renal failure due to polycystic renal disease. Acta physiologica latino americana, 1974, Volume: 24, Issue:5 Topics: Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Humans; Hypertension, Renal; Kidney; Kidney Failure, Chronic; Polycystic Kidney Diseases; Renin; Sodium; Water-Electrolyte Balance	1974
Dynamic functions of angiotensin in hypertension: renal effects as the basic cause of chronic hypertension. Acta physiologica latino americana, 1974, Volume: 24, Issue:5 Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Dogs; Glomerular Filtration Rate; Hypertension, Renal; Kidney; Natriuresis; Sodium Chloride	1974
Cardiovascular reactivity in acute and chronic renal hypertensive dogs. Circulation research, 1966, Volume: 18, Issue:4 Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Cardiovascular System; Chronic Disease; Dogs; Hindlimb; Hypertension; Hypertension, Renal; Reference Values; Vasoconstriction	1966